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 Materials and Methods 
Unless noted in the specific procedure, reactions were performed in non-dry glassware 
under an air atmosphere.  Dried and deoxygated solvents (Fisher Scientific) were 
prepared by passage through columns of activated aluminum before use.[1]  Anhydrous 
carbon tetrachloride was purchased from Sigma Aldrich and used as received.  Methanol 
(Fisher Scientific) was distilled from magnesium methoxide immediately prior to use.      
Commercial reagents (Sigma Aldrich or Alfa Aesar) were used as received with the 
exception of δ-valerolactam (Oakwood Chemical), dichloro(p-cymene)ruthenium(II) 
dimer (Strem Chemicals), triphenylphosphine (Sigma Aldrich) , lithium 
hexamethyldisilazide (Sigma Aldrich), zinc(II) chloride (Sigma Aldrich), and lithium tri-
tert-butoxyaluminum hydride (Sigma Aldrich) which were stored in a nitrogen-filled 
govebox.  Diisopropylamine (Oakwood Chemical) and trimethylsilyl chloride (Alfa 
Aesar) were distilled from calcium hydride immediately prior to use.  The acetic acid (J. 
T. Baker) and acetic anhydride (Sigma Aldrich) used in the allylic acetoxylation reactions 
were stored in a 1:1 mixture over activated MS4Å.  Brine is defined as a saturated 
aqueous solution of sodium chloride.  Reactions requiring external heat were modulated 
to the specified temperatures using an IKAmag temperature controller.  Reaction progress 
was monitored by thin-layer chromatography (TLC) or Agilent 1290 UHPLC-LCMS.  
TLC was performed using E. Merck silica gel 60 F254 precoated plates (0.25 mm) and 
visualized by UV fluorescence quenching, potassium permanganate, or p-anisaldehyde 
staining.  SiliaFlash P60 Academic Silica gel (particle size 0.040-0.063 mm) was used 
for flash chromatography.  1H and 13C NMR spectra were recorded on a Varian Inova 500 
spectrometer (500 MHz and 126 MHz, respectively) or a Bruker AV III HD spectrometer 
equipped with a Prodigy liquid nitrogen temperature cryoprobe (400 MHz and 101 MHz, 
respectively), and are reported in terms of chemical shift relative to residual CHCl3 (δ 
7.26 and δ 77.16 ppm, respectively).  Data for 1H NMR spectra are reported as follows: 
chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration).  Abbreviations 
are used as follows: s = singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, m 
= complex multiplet.  Infrared (IR) spectra were recorded on a Perkin Elmer Paragon 
1000 spectrometer using thin film samples on NaCl plates, and are reported in frequency 
of absorption (cm–1).  High-resolution mass spectra (HRMS) were obtained from the 
Caltech Mass Spectral Facility using a JEOL JMS-600H High Resolution Mass 
Spectrometer with fast atom bombardment (FAB+) ionization mode or were acquired 
using an Agilent 6200 Series TOF with an Agilent G1978A Multimode source in 
electrospray ionization (ESI+) mode.  Melting points were measured with a BÜCHI 
Melting Point B-545 apparatus. 
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 General Experimental Procedures 
 
 
General Procedure A.  Benzyl protection of lactams. 
To a flame-dried round-bottom flask with a magnetic stir bar were added sodium hydride 
(60% dispersion in mineral oil, 56.5 mmol, 1.13 equiv) and THF (16 mL).  The flask was 
capped with a rubber septum, put under a nitrogen atmosphere, and cooled to 0 °C using 
an ice water bath.  A solution of lactam S1 (50.0 mmol, 1.00 equiv) in THF (75 mL) was 
added rapidly dropwise by syringe, and the resulting mixture was allowed to warm to 23 
°C and stir for 2 hours.  Benzyl bromide (53.5 mmol, 1.07 equiv) was added dropwise by 
syringe, and the mixture stirred for another 2 hours.  Upon completion (as determined by 
TLC analysis), the suspension was diluted with water (300 mL) and extracted with ethyl 
acetate (3 x 300 mL).  The combined organic layers were washed with brine (1 x 300 
mL), dried over magnesium sulfate, filtered, and concentrated in vacuo.  The crude 
residue was purified by silica gel column chromatography, using mixture of hexanes and 
ethyl acetate as eluent.  The products were obtained in 90–99% yield. 
 
 
General Procedure B.  Installation of the α-substituents. 
To a flame-dried round-bottom flask with a magnetic stir bar were added 
diisopropylamine (25.4 mmol, 1.2 equiv) and THF (13 mL) by syringe.  The solution was 
stirred under nitrogen and cooled to 0 °C using an ice water bath.  n-Butyllithium (2.5 M 
in hexane, 25.1 mmol, 1.19 equiv) was added rapidly dropwise by syringe, and the 
solution was allowed to stir at 0 °C for 20 minutes.  Meanwhile, lactam S2 (21.1 mmol, 
1.00 equiv) was dissolved in THF (200 mL) in a flame-dried round-bottom flask under 
nitrogen and cooled to 0 °C using an ice water bath.  The freshly prepared LDA solution 
was transferred to the lactam solution rapidly dropwise via syringe, and the mixture was 
allowed to stir at 0 °C for 45 minutes.  The solution was then cooled to –78 °C using a 
dry ice and acetone bath, and the appropriate alkyl halide (27.5 mmol, 1.30 equiv) was 
added dropwise by syringe.  The flask was placed in an ice water bath and allowed to 
gradually warm to 23 °C overnight.  Upon completion (as determined by TLC analysis), 
the reaction mixture was quenched by the addition of saturated aqueous ammonium 
chloride solution (400 mL), and the aqueous layer extracted with chloroform (3 x 300 
mL).  The combined organic layers were washed with brine (1 x 300 mL), dried over 
sodium sulfate, filtered, and concentrated in vacuo.  The crude residue was purified by 
silica gel column chromatography using mixtures of hexanes and ethyl acetate as eluent. 
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 To a flame-dried round-bottom flask with a magnetic stir bar were added 
diisopropylamine (29.3 mmol, 1.50 equiv) and THF (15 mL) by syringe.  The solution 
was stirred under nitrogen and cooled to 0 °C using an ice water bath.  n-Butyllithium 
(2.5 M in hexane, 29.1 mmol, 1.49 equiv) was added rapidly dropwise by syringe, and 
the solution was allowed to stir at 0 °C for 20 minutes.  Meanwhile, the mono-alkylated 
intermediate lactam (19.5 mmol, 1.00 equiv) was dissolved in THF (61 mL) in a flame-
dried round-bottom flask under nitrogen and cooled to 0 °C using an ice water bath.  The 
freshly prepared LDA solution was transferred to the lactam solution rapidly dropwise 
via syringe, and the mixture was allowed to stir at 0 °C for 45 minutes.  The solution was 
then cooled to –78 °C using a dry ice and acetone bath, and allyl bromide (117.0 mmol, 
6.00 equiv) was added dropwise by syringe.  The flask was placed in an ice water bath 
and allowed to gradually warm to 23 °C overnight.  Upon completion (as determined by 
TLC analysis), the reaction mixture was quenched by the addition of saturated aqueous 
ammonium chloride solution (300 mL), and the aqueous layer extracted with chloroform 
(3 x 200 mL).  The combined organic layers were washed with brine (1 x 200 mL), dried 
over sodium sulfate, filtered, and concentrated in vacuo.  The crude residue was purified 
by silica gel column chromatography using mixtures of hexanes and ethyl acetate as 
eluent.  The products were obtained in 8–40% yield over two steps. 
 
 
General Procedure C.  Optimization of the allylic acetoxylation reaction. 
To a flame-dried 25 mL round-bottom flask with a magnetic stir bar were added, in order, 
the appropriate lactam 3 (0.10 mmol, 1.00 equiv), the appropriate palladium(II) catalyst 
(0.075 mmol or 0.05 mmol, 0.075 equiv or 0.05 equiv), Oxone (0.15 mmol or 0.25 mmol, 
1.50 equiv or 2.50 equiv), and (if indicated) hot, activated 4 Å molecular sieves (80 mg).  
The flask was then capped with a rubber septum and evacuated and backfilled twice with 
nitrogen.  The appropriate solvent mixture (total volume 1 mL, 5:2 acetonitrile:acetic acid 
or 5:1:1 acetonitrile:acetic acid:acetic anhydride) was added by syringe.  The resulting 
suspension was stirred under nitrogen for 5 minutes at 23 °C and then heated to 60 °C in 
an oil bath.  Upon completion (as determined by TLC analysis), the flask was allowed to 
cool to 23 °C and the contents were filtered through a short plug of silica gel, rinsing with 
ethyl acetate.  The filtrate was adsorbed onto silica gel (approx. 1 g), which was then 
flushed with ethyl acetate.  The eluent was concentrated to give the crude product as an 
oil.  After NMR analysis to determine the acetate:enal ratio, the crude residue was 
purified by silica gel column chromatography, using mixtures of hexanes and ethyl 
acetate as eluent. 
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General Procedure D.  Allylic acetoxylation of α-allyl lactams. 
To a flame-dried 25 mL round-bottom flask with a magnetic stir bar were added, in order, 
lactam 7 (0.20 mmol, 1.00 equiv), palladium(II) hexafluoroacetylacetonate (8 mg, 0.015 
mmol, 0.075 equiv), Oxone (154 mg, 0.50 mmol, 2.50 equiv), and hot, activated 4 Å 
molecular sieves (160 mg).  The flask was then capped with a rubber septum and 
evacuated and backfilled twice with nitrogen.  Acetonitrile (1.43 mL) and 1:1 acetic 
acid:acetic anhydride (571 µL) were added by syringe.  The resulting suspension was 
stirred under nitrogen for 5 minutes at 23 °C and then heated to 60 °C in an oil bath.  
Upon completion (as determined by TLC analysis), the flask was allowed to cool to 23 
°C and the contents were filtered through a short plug of silica gel, rinsing with ethyl 
acetate.  The filtrate was adsorbed onto silica gel (approx. 2 g), which was then flushed 
with ethyl acetate.  The eluent was concentrated to give the crude product as an oil.  After 
NMR analysis to determine the acetate:enal ratio, the crude residue was purified by silica 
gel column chromatography, using mixtures of hexanes and ethyl acetate as eluent. 
 
 
General Procedure E.  Enal formation from α-allyl lactams. 
To a 25 mL round-bottom flask with a magnetic stir bar were added, in order, lactam 7 
(0.20 mmol, 1.00 equiv), palladium(II) acetate (3 mg, 0.015 mmol, 0.075 equiv), and 
Oxone (154 mg, 0.50 mmol, 2.50 equiv).  Acetonitrile (1.82 mL), acetic acid (183 µL, 
3.20 mmol, 16.00 equiv), and water (29 µL, 1.60 mmol, 8.00 equiv) were added by 
syringe.  The resulting suspension was stirred for 5 minutes at 23 °C and then heated to 
50 °C in an oil bath.  Upon completion (as determined by TLC analysis), the flask was 
allowed to cool to 23 °C and anhydrous magnesium sulfate (approx. 200 mg) was added.  
After stirring for 5 minutes the contents were filtered through a short plug of silica gel, 
rinsing with ethyl acetate.  The filtrate was adsorbed onto silica gel (approx. 2 g), which 
was then flushed with ethyl acetate.  The eluent was concentrated to give the crude 
product as an oil.  After NMR analysis to determine the acetate:enal ratio, the crude 
residue was purified by silica gel column chromatography, using mixtures of hexanes and 
ethyl acetate as eluent. 
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 Substrate Synthesis and Characterization Data 
 
 
Compounds of the general structures 1 (not used in this work) and 2, including one used 
in this work (R1 = Bz, R2 = Et, n = 1; starting material for entry 1 of Table 1) may be 
prepared as previously reported by our research group.[2] 
 
 
1-benzylpiperidin-2-one (S2a): 
Lactam S2a was prepared from δ-valerolactam (S1a) using General Procedure A.  
Characterization data match those reported in the literature.[3] 
 
 
1-benzylazepan-2-one (S2c): 
Lactam S2c was prepared from ε-caprolactam (S1b) using General Procedure A.  
Characterization data match those reported in the literature.[4] 
 
 
1-benzylpyrrolidin-2-one (S2d): 
Lactam S2d was prepared from 2-pyrrolidinone (S1c) using General Procedure A.  
Characterization data match those reported in the literature.[5] 
 
 
3-allyl-1-benzyl-3-ethylpiperidin-2-one (7a): 
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 Lactam 7a was prepared from S2a using General Procedure B.  Rf = 0.40 (33% ethyl 
acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.34–7.27 (m, 2H), 7.26–7.20 (m, 
3H), 5.78 (dddd, J = 16.7, 10.5, 8.1, 6.7 Hz, 1H), 5.10–5.05 (m, 1H), 5.06–5.03 (m, 2H), 
4.60 (d, J = 14.6 Hz, 1H), 4.56 (d, J = 14.6 Hz, 1H), 3.22–3.10 (m, 2H), 2.55 (ddt, J = 
13.5, 6.7, 1.3 Hz, 1H), 2.21 (ddt, J = 13.5, 8.0, 1.1 Hz, 1H), 1.83 (dq, J = 13.6, 7.5 Hz, 
1H), 1.78–1.63 (m, 3H), 1.52 (dq, J = 13.6, 7.5 Hz, 1H), 0.88 (t, J = 7.5 Hz, 3H); 13C 
NMR (CDCl3, 126 MHz) δ 174.5, 137.7, 135.0, 128.6, 128.1, 127.3, 117.8, 50.6, 47.8, 
45.3, 31.6, 28.9, 19.8, 8.9; IR (Neat Film, NaCl) 2938, 1633, 1488, 1453, 1352, 1196, 
913, 736 cm–1; HRMS (ESI+) m/z calc’d for C17H24NO [M+H]+: 258.1852, found 
258.1856. 
 
 
3-allyl-1-benzyl-3-methylpiperidin-2-one (7b): 
Lactam 7b was prepared from S2a using General Procedure B.  Rf = 0.50 (33% ethyl 
acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.32–7.27 (m, 2H), 2.26–2.20 (m, 
3H), 5.81–5.71 (m, 1H), 5.11–5.04 (m, 2H), 4.62 (d, J = 14.6 Hz, 1H), 4.50 (d, J = 14.6 
Hz, 1H), 3.24–3.10 (m, 2H), 2.57 (ddt, J = 13.5, 6.7, 1.3 Hz, 1H), 2.23 (ddt, J = 13.4, 8.1, 
1.0 Hz, 1H) 1.89–1.80 (m, 1H), 1.80–1.69 (m, 2H), 1.58–1.47 (m, 1H), 1.25 (s, 3H); 13C 
NMR (CDCl3, 126 MHz) δ 175.1, 137.7, 143.6, 128.6, 128.0, 127.3, 118.1, 50.5, 47.9, 
44.5, 41.6, 32.6, 26.0, 19.4; IR (Neat Film, NaCl) 2936, 1634, 1488, 1432, 1349, 1196, 
914, 750 cm–1; HRMS (ESI+) m/z calc’d for C16H22NO [M+H]+: 244.1696, found 
244.1699. 
 
 
3-allyl-1,3-dibenzylpiperidin-2-one (7c): 
Lactam 7c was prepared from S2a using General Procedure B.  Rf = 0.40 (33% ethyl 
acetate in hexanes); 1H NMR (CDCl3, 500 MHz) 7.32–7.13 (m, 10H), 5.82 (dddd, J = 
16.8, 10.6, 8.2, 6.5 Hz, 1H), 5.15–5.11 (m, 1H), 5.11–5.06 (m, 1H), 4.68 (d, J = 14.5 Hz, 
1H), 4.48 (d, J = 14.6 Hz, 1H), 3.38 (d, J = 13.0 Hz, 1H), 3.06 (ddd, J = 12.0, 7.4, 4.6 Hz, 
1H), 2.99–2.87 (m, 1H), 2.72 (ddt, J = 13.4, 6.5, 1.4 Hz, 1H), 2.61 (d, J = 13.1 Hz, 1H), 
2.21 (ddt, J = 13.4, 8.2, 1.0 Hz, 1H), 1.78–1.68 (m, 2H), 1.64 (qdd, J = 11.9, 5.9, 2.7 Hz, 
1H), 1.46–1.34 (m, 1H); 13C NMR (CDCl3, 126 MHz) δ 173.8, 138.3, 137.4, 134.5, 
130.8, 128.5, 128.1, 128.1, 127.3, 126.4, 118.5, 50.8, 47.8, 46.7, 44.8, 44.6, 28.6, 19.7; 
IR (Neat Film, NaCl) 3027, 2939, 1631, 1495, 1453, 1353, 1194, 916, 742 cm–1; HRMS 
(ESI+) m/z calc’d for C22H26NO [M+H]+: 320.2009, found 320.2019. 
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3-allyl-1-benzyl-3-propylpiperidin-2-one (7d): 
Lactam 7d was prepared from S2a using General Procedure B.  Rf = 0.50 (33% ethyl 
acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.35–7.29 (m, 2H), 7.27–7.20 (m, 
3H), 5.90–5.66 (m, 1H), 5.10–5.06 (m, 1H), 5.06–5.04 (m, 1H), 4.61 (d, J = 14.5 Hz, 
1H), 4.55 (d, J = 14.5 Hz, 1H), 3.16 (td, J = 5.4, 4.6, 2.2 Hz, 2H), 2.56 (ddt, J = 13.5, 6.7, 
1.3 Hz, 1H), 2.22 (ddt, J = 13.5, 8.1, 1.0 Hz, 1H), 1.83–1.57 (m, 5H), 1.55–1.41 (m, 1H), 
1.41–1.32 (m, 1H), 1.32–1.21 (m, 1H), 0.91 (t, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 126 
MHz) δ 174.4, 137.7, 134.9, 128.5, 128.1, 127.2, 117.8, 50.5, 47.7, 45.1, 43.7, 41.4, 29.5, 
19.8, 17.6, 14.8; IR (Neat Film, NaCl) 2955, 1632, 1487, 1437, 1350, 1194, 913, 734 cm–
1; HRMS (ESI+) m/z calc’d for C18H26NO [M+H]+: 272.2009, found 272.2014. 
 
 
3-allyl-1-benzyl-3-(2-methoxyethyl)piperidin-2-one (7e): 
Lactam 7e was prepared from S2a using General Procedure B.  Rf = 0.3 (33% ethyl 
acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.34–7.27 (m, 2H), 7.27–7.20 (m, 
3H), 5.86–5.65 (m, 1H), 5.08 (dtd, J = 13.3, 2.4, 1.1 Hz, 2H), 4.62 (d, J = 14.6 Hz, 1H), 
4.52 (d, J = 14.5 Hz, 1H), 3.56–3.37 (m, 2H), 3.29 (s, 3H), 3.24–3.12 (m, 2H), 2.56 (ddt, 
J = 13.6, 6.7, 1.3 Hz, 1H), 2.26 (ddt, J = 13.5, 8.0, 1.0 Hz, 1H), 2.09 (ddd, J = 14.1, 7.7, 
6.5 Hz, 1H), 1.83–1.63 (m, 5H); 13C NMR (CDCl3, 126 MHz) δ 173.9, 137.7, 134.4, 
128.6, 128.1, 127.3, 118.4, 69.7, 58.7, 50.7, 47.9, 44.0, 43.7, 38.0, 30.1, 19.7; IR (Neat 
Film, NaCl) 2925, 1632, 1487, 1452, 1195, 1114, 915, 736 cm–1; HRMS (ESI+) m/z 
calc’d for C18H26NO2 [M+H]+: 288.1958, found 288.1966. 
 
 
1-benzyl-3-phenylpiperidin-2-one (S3): 
Lactam S3 was prepared from S2a following a known procedure.2a  To a flame-dried 
round-bottom flask with a magnetic stir bar were added lactam S2a (662 mg, 3.50 mmol, 
2.20 equiv) and THF (6.4 mL).  The solution was stirred under nitrogen and cooled to –
20 °C using a dry ice and acetone bath.  A solution of lithium hexamethyldisilazide (532 
mg, 3.18 mmol, 2.00 equiv) in THF (1.4 mL) was added by syringe, and the reaction 
BnN
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 mixture was allowed to stir at –20 °C for 20 minutes.  A solution of zinc(II) chloride (477 
mg, 3.50 mmol, 2.20 equiv) in THF (7 mL) was added, and the reaction mixture was 
allowed to stir at –20 °C for another 20 minutes, after which it was transferred via syringe 
to a flame-dried round-bottom flask with a magnetic stir bar and a reflux condenser 
containing tris(dibenzylideneacetone)dipalladium(0) (23 mg, 0.025 mmol, 0.015 equiv), 
DavePhos (30 mg, 0.076 mmol, 0.048 equiv), bromobenzene (169 µL, 1.59 mmol, 1.00 
equiv), and THF (3.2 mL).  The mixture was heated to 65 °C for 10 hours.  Upon 
completion (as determined by TLC analysis), the reaction mixture was allowed to cool to 
23 °C, quenched by the addition of saturated aqueous ammonium chloride solution (100 
mL), and the aqueous layer was extracted with ether (3 x 200 mL).  The combined 
organic layers were dried over magnesium sulfate and concentrated in vacuo.  The crude 
residue was purified by silica gel column chromatography (20% ethyl aceate in hexanes 
to 25% ethyl acetate in hexanes) to provide lactam S3 as a colorless oil (141 mg, 15% 
yield).  Characterization data match those reported in the literature.5 
 
 
3-allyl-1-benzyl-3-phenylpiperidin-2-one (7f): 
To a flame-dried round-bottom flask with a magnetic stir bar were added 
diisopropylamine (348 µL, 2.48 mmol, 1.50 equiv) and THF (1.3 mL) by syringe.  The 
solution was stirred under nitrogen and cooled to 0 °C using an ice water bath.  n-
Butyllithium (2.5 M in hexane, 983 µL, 2.46 mmol, 1.49 equiv) was added rapidly 
dropwise by syringe, and the solution was allowed to stir at 0 °C for 20 minutes.  
Meanwhile, lactam S3 (439 mg, 1.65 mmol, 1.00 equiv) was dissolved in THF (5.3 mL) 
in a flame-dried round-bottom flask under nitrogen and cooled to 0 °C using an ice water 
bath.  The freshly prepared LDA solution was transferred to the lactam solution rapidly 
dropwise via syringe, and the mixture was allowed to stir at 0 °C for 45 minutes.  The 
solution was then cooled to –78 °C using a dry ice and acetone bath, and allyl bromide 
(857 µL, 9.90 mmol, 6.00 equiv) was added dropwise by syringe.  The flask was placed 
in an ice water bath and allowed to gradually warm to 23 °C overnight.  Upon completion 
(as determined by TLC analysis), the reaction mixture was quenched by the addition of 
saturated aqueous ammonium chloride solution (100 mL), and the aqueous layer 
extracted with chloroform (3 x 75 mL).  The combined organic layers were washed with 
brine (1 x 100 mL), dried over sodium sulfate, filtered, and concentrated in vacuo.  The 
crude residue was purified by silica gel column chromatography (5% ethyl aceate in 
hexanes) to provide lactam 7f as a colorless oil (332 mg, 66% yield).  Rf = 0.4 (10% ethyl 
acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.41–7.26 (m, 9H), 7.25–7.19 (m, 
1H), 5.76 (dddd, J = 17.1, 10.2, 8.2, 6.1 Hz, 1H), 5.14–5.04 (m, 2H), 4.69 (s, 2H), 3.28–
3.16 (m, 1H), 3.12 (dddd, J = 12.1, 5.2, 3.7, 1.3 Hz, 1H), 2.96 (ddt, J = 13.5, 6.1, 1.4 Hz, 
1H), 2.53 (ddt, J = 13.6, 8.2, 1.0 Hz, 1H), 2.19 (dtd, J = 13.9, 4.0, 1.3 Hz, 1H), 2.12–1.97 
(m, 1H), 1.72–1.61 (m, 2H); 13C NMR (CDCl3, 126 MHz) δ 172.4, 144.0, 137.6, 135.4, 
128.7, 128.5, 128.3, 127.4, 126.8, 126.6, 118.2, 51.2, 50.8, 47.5, 45.8, 31.4, 19.0; IR 
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O
S4
Ph
BnN
O
7f
Ph
LDA, THF, 0 °C;
allyl–Br, –78→23 °C
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 (Neat Film, NaCl) 3061, 2943, 1635, 1495, 1442, 1352, 1197, 916, 761, 699 cm–1; 
HRMS (ESI+) m/z calc’d for C21H24NO [M+H]+: 306.1852, found 306.1850. 
 
 
3-allyl-3-ethyl-1-methylpiperidin-2-one (7g): 
To a flame-dried round-bottom flask with a magnetic stir bar were added sodium hydride 
(60% dispersion in mineral oil, 122 mg, 3.06 mmol, 1.10 equiv) and THF (5 mL).  The 
flask was capped with a rubber septum, put under a nitrogen atmosphere, and cooled to 0 
°C using an ice water bath.  A solution of lactam 7h (preparation described below, 465 
mg, 2.78 mmol, 1.00 equiv) in THF (15 mL) was added rapidly dropwise by syringe, and 
the resulting mixture was allowed to warm to 23 °C and stir for 2 hours.  Methyl iodide 
(191 µL, 3.06 mmol, 1.10 equiv) was added dropwise by syringe, and the mixture stirred 
for another 2 hours.  Upon completion (as determined by TLC analysis), the suspension 
was diluted with water (100 mL) and extracted with ethyl acetate (3 x 100 mL).  The 
combined organic layers were washed with brine (1 x 100 mL), dried over magnesium 
sulfate, filtered, and concentrated in vacuo.  The crude residue was purified by silica gel 
column chromatography (40% ethyl acetate in hexanes) to provide lactam 7g as a 
colorless oil (490 mg, 97% yield).  Rf = 0.4 (33% ethyl acetate in hexanes); 1H NMR 
(CDCl3, 500 MHz) δ 5.77–5.61 (m, 1H), 5.05–5.01 (m, 1H), 5.00 (t, J = 1.2 Hz, 1H), 
3.29–3.15 (m, 2H), 2.89 (s, 3H), 2.45 (ddt, J = 13.6, 6.7, 1.4 Hz, 1H), 2.15 (ddt, J = 13.6, 
8.1, 1.1 Hz, 1H), 1.84–1.58 (m, 5H), 1.46 (dq, J = 13.7, 7.4 Hz, 1H), 0.82 (t, J = 7.5 Hz, 
3H); 13C NMR (CDCl3, 126 MHz) δ 174.6, 135.1, 117.6, 50.5, 45.1, 43.0, 35.2, 31.3, 
28.9, 19.7, 8.0; IR (Neat Film, NaCl) 2938, 1635, 1499, 1458, 1398, 1357, 1201, 911 cm–
1; HRMS (ESI+) m/z calc’d for C11H20NO [M+H]+: 182.1539, found 182.1542. 
 
 
3-ethylpiperidin-2-one (S4): 
Lactam S4 was prepared from S1a following a known procedure.[6]  To a flame-dried 
round-bottom flask with a magnetic stir bar were added lactam S1a (2.25 g, 22.7 mmol, 
1.00 equiv) and THF (50 mL).  The solution was stirred under nitrogen and cooled to –78 
°C using a dry ice and acetone bath.  n-Butyllithium (2.5 M in hexane, 18.3 mL, 45.7 
mmol, 2.01 equiv) was added dropwise by syringe, and the reaction mixture was allowed 
to warm to 0 °C and stir for 1 hour.  Ethyl iodide (2.73 mL, 34.1 mmol, 1.50 equiv) was 
added dropwise by syringe, and the solution was stirred for 45 minutes at 0 °C.  Upon 
completion (as determined by TLC analysis), the mixture was quenched with saturated 
aqueous ammonium chloride solution (100 mL) and the aqueous layer was extracted with 
chloroform (3 x 200 mL).  The combined organic layers were washed with brine (1 x 200 
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 mL), dried over sodium sulfate, and concentrated in vacuo.  The crude residue was 
purified by silica gel column chromatography (ethyl acetate) to provide lactam S4 as a 
white solid (2.60 g mg, 90% yield).  Characterization data match those reported in the 
literature.7 
 
 
3-allyl-3-ethylpiperidin-2-one (7h): 
Lactam 7h was prepared from S4 following a known procedure.6  To a flame-dried 
round-bottom flask with a magnetic stir bar were added lactam S4 (2.60 g, 20.4 mmol, 
1.00 equiv) and THF (60 mL).  The solution was stirred under nitrogen and cooled to –78 
°C using a dry ice and acetone bath.  n-Butyllithium (2.5 M in hexane, 8.24 mL, 20.6 
mmol, 1.01 equiv) was added dropwise by syringe, and the reaction mixture was allowed 
to warm to 0 °C and stir for 1.25 hours.  Trimethylsilyl chloride (3.77 mL, 22.5 mmol, 
1.10 equiv) was added rapidly by syringe, and the reaction mixture was allowed to stir for 
1.75 hours at 0 °C.  Meanwhile, to a flame-dried round-bottom flask with a magnetic stir 
bar were added diisopropylamine (4.29 mL, 30.6 mmol, 1.50 equiv) and THF (15 mL) by 
syringe.  The amine solution was stirred under nitrogen and cooled to 0 °C using an ice 
water bath.  n-Butyllithium (2.5 M in hexane, 12.2 mL, 30.4 mmol, 1.49 equiv) was 
added rapidly dropwise by syringe, and the solution was allowed to stir at 0 °C for 20 
minutes.  The freshly prepared LDA solution was then added to the reaction mixture 
rapidly by syringe, and the resulting solution was stirred for 45 minutes at 0 °C.  The 
solution was then cooled to –78 °C using a dry ice and acetone bath, and allyl bromide 
(21 mL, 250 mmol, 12.3 equiv) was added dropwise by syringe.  The reaction mixture 
was allowed to warm to 0 °C and stir for 1.25 hours.  Upon completion (as determined by 
TLC analysis), the mixture was quenched with saturated aqueous ammonium chloride 
solution (100 mL) and the aqueous layer was extracted with chloroform (3 x 200 mL).  
The combined organic layers were washed with 1 M aqueous hydrochloric acid (2 x 100 
mL), water (1 x 100 mL), brine (1 x 100 mL), dried over sodium sulfate, and 
concentrated in vacuo.  The crude residue was purified by silica gel column 
chromatography (50% ethyl acetate in hexanes) to provide lactam 7h as a colorless oil 
(2.09 g, 61% yield).  Characterization data match those reported in the literature.8 
 
 
3-allyl-1-benzylpiperidin-2-one (7i): 
To a flame-dried round-bottom flask with a magnetic stir bar were added 
diisopropylamine (2.91 mL, 20.8 mmol, 1.05 equiv) and THF (10 mL) by syringe.  The 
solution was stirred under nitrogen and cooled to 0 °C using an ice water bath.  n-
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 Butyllithium (2.5 M in hexane, 8.71 mL, 21.8 mmol, 1.10 equiv) was added rapidly 
dropwise by syringe, and the solution was allowed to stir at 0 °C for 30 minutes before 
being cooled to –78 °C in a dry ice and acetone bath.  A solution of lactam S2a (3.75 g, 
19.8 mmol, 1.00 equiv) in THF (60 mL) was added dropwise by cannula.  The reaction 
mixture was stirred at –78 °C for 4 hours.  Allyl bromide (1.79 mL, 20.8 mmol, 1.05 
equiv) was added dropwise by syringe, and the reaction mixture was allowed to gradually 
warm to 23 °C and stir for 16 h.  Upon completion (as determined by TLC analysis) the 
reaction mixture was quenched by the addition of saturated aqueous ammonium chloride 
solution (200 mL), and the aqueous layer extracted with chloroform (3 x 200 mL).  The 
combined organic layers were washed with brine (1 x 200 mL), dried over sodium 
sulfate, filtered, and concentrated in vacuo.  The crude residue was purified by silica gel 
column chromatography (25% ethyl aceate in hexanes) to provide lactam 7i as a colorless 
oil (2.77 g, 61% yield).  Rf = 0.7 (50% ethyl acetate in hexanes); characterization data 
match those reported in the literature.[7] 
 
 
3-allyl-3-ethyl-1-(4-methoxyphenyl)piperidin-2-one (7j): 
The conditions for this transformation were adapted from a known procedure.[8]  To a 
flame-dried round-bottom flask with a magnetic stir bar were added lactam 7h (1.00 g, 
5.98 mmol, 1.20 equiv) and DMF (6 mL).  The solution was stirred under nitrogen and 
copper(I) iodide (190 mg, 1.00 mmol, 0.20 equiv), potassium phosphate tribasic (2.12 g, 
10.0 mmol, 2.00 equiv), N,N’-dimethylethylenediamine (108 µL), and 4-bromoanisole 
(630 µL, 5.04 mmol, 1.00 equiv) were added.  The heterogeneous mixture was then 
heated to 110 °C under nitrogen for 20 hours.  Upon completion (as determined by 
LCMS analysis), the mixture was filtered through a plug of sodium sulfate, rinsing with 
dichloromethane.  The filtrate was washed with water (3 x 100 mL), dried over sodium 
sulfate, filtered, and concentrated in vacuo.  The crude residue was purified by silica gel 
column chromatography (20% ethyl acetate in hexanes) to provide lactam 7j as a 
colorless oil (203 mg, 12% yield).  Rf = 0.3 (20% ethyl acetate in hexanes); 1H NMR 
(CDCl3, 500 MHz) δ 7.17–7.04 (m, 2H), 6.95–6.83 (m, 2H), 6.01–5.69 (m, 1H), 5.14–
5.10 (m, 1H), 5.10 (s, 1H), 3.80 (s, 3H), 3.58 (t, J = 5.9 Hz, 2H), 2.60 (ddt, J = 13.5, 6.7, 
1.3 Hz, 1H), 2.23 (ddt, J = 13.4, 8.1, 1.0 Hz, 1H), 2.00–1.77 (m, 5H), 1.57 (dq, J = 13.6, 
7.4 Hz, 1H), 0.95 (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 174.9, 158.0, 137.0, 
135.1, 127.5, 118.0, 114.4, 55.6, 52.5, 45.7, 43.7, 31.9, 29.3, 20.6, 9.0; IR (Neat Film, 
NaCl) 3072, 2937, 1646, 1511, 1457, 1293, 1243, 1199, 1105, 1134, 913, 829 cm–1; 
HRMS (ESI+) m/z calc’d for C17H24NO2 [M+H]+: 274.1802, found 274.1813. 
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3-allyl-3-ethyl-1-(2-methylallyl)piperidin-2-one (7k): 
To a flame-dried round-bottom flask with a magnetic stir bar were added lactam 7h (400 
mg, 2.40 mmol, 1.00 equiv) and THF (12 mL).  The flask was capped with a rubber 
septum, put under an argon atmosphere, and cooled to 0 °C using an ice water bath.  
Sodium hydride (60% dispersion in mineral oil, 192 mg, 4.80 mmol, 2.00 equiv) was 
then added in one portion, and the suspension was allowed to warm to 23 °C and stir for 
2 hours.  The suspension was then cooled to 0 °C using an ice water bath, and 3-bromo-2-
methylpropene (267 µL, 2.64 mmol, 1.10 equiv) was added by syringe.  The suspension 
was allowed to warm to 23 °C and stir for 1 hour.  Upon completion (as determined by 
TLC analysis), the reaction mixture was diluted with water (100 mL) and extracted with 
ethyl acetate (3 x 100 mL).  The combined organic layers were washed with brine (1 x 
100 mL), dried over sodium sulfate, filtered, and concentrated in vacuo.  The crude 
residue was purified by silica gel column chromatography (10% ethyl acetate in hexanes) 
to provide lactam 7k as a colorless oil (531 mg, >99% yield).  Rf = 0.5 (20% ethyl acetate 
in hexanes); 1H NMR (CDCl3, 500 MHz) δ 5.86–5.62 (m, 1H), 5.07–5.04 (m, 1H), 5.04–
5.02 (m, 1H), 4.85 (q, J = 1.5 Hz, 1H), 4.76 (dt, J = 2.4, 1.1 Hz, 1H), 4.02–3.80 (m, 2H), 
3.24–3.08 (m, 2H), 2.58–2.38 (m, 1H), 2.18 (ddt, J = 13.5, 8.2, 1.1 Hz, 1H), 1.89–1.68 
(m, 5H), 1.67 (s, 3H), 1.56–1.45 (m, 1H), 0.87 (td, J = 7.4, 1.2 Hz, 3H); 13C NMR 
(CDCl3, 126 MHz) δ 174.3, 140.9, 135.1, 117.8, 112.0, 52.7, 47.6, 45.3, 43.4, 31.6, 29.0, 
20.2, 19.9, 8.9; IR (Neat Film, NaCl) 3074, 2939, 1637, 1488, 1458, 1440, 1346, 1285, 
1197, 1000, 911 cm–1; HRMS (ESI+) m/z calc’d for C14H24NO [M+H]+: 222.1852, found 
222.1860. 
 
 
3-allyl-1-cinnamyl-3-ethylpiperidin-2-one (7l): 
To a flame-dried round-bottom flask with a magnetic stir bar were added lactam 7h (400 
mg, 2.40 mmol, 1.00 equiv) and THF (12 mL).  The flask was capped with a rubber 
septum, put under an argon atmosphere, and cooled to 0 °C using an ice water bath.  
Sodium hydride (60% dispersion in mineral oil, 192 mg, 4.80 mmol, 2.00 equiv) was 
then added in one portion, and the suspension was allowed to warm to 23 °C and stir for 
2 hours.  The suspension was then cooled to 0 °C using an ice water bath, and 3-bromo-1-
phenyl-1-propene (520 mg, 2.64 mmol, 1.10 equiv) was added by syringe.  The 
suspension was allowed to warm to 23 °C and stir for 2 hours.  Upon completion (as 
determined by TLC analysis), the reaction mixture was diluted with water (100 mL) and 
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 extracted with ethyl acetate (3 x 100 mL).  The combined organic layers were washed 
with brine (1 x 100 mL), dried over sodium sulfate, filtered, and concentrated in vacuo.  
The crude residue was purified by silica gel column chromatography (20% ethyl acetate 
in hexanes) to provide lactam 7l as a colorless oil (676 mg, >99% yield).  Rf = 0.3 (20% 
ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.39–7.33 (m, 2H), 7.31 (ddd, J 
= 7.7, 6.7, 1.2 Hz, 2H), 7.26–7.20 (m, 1H), 6.48 (dt, J = 15.7, 1.5 Hz, 1H), 6.14 (dt, J = 
15.8, 6.5 Hz, 1H), 5.90–5.57 (m, 1H), 5.08 (ddt, J = 5.0, 2.3, 1.3 Hz, 1H), 5.06 (t, J = 1.2 
Hz, 1H), 4.14 (dd, J = 6.5, 1.4 Hz, 2H), 3.42–3.13 (m, 2H), 2.54 (ddt, J = 13.5, 6.7, 1.3 
Hz, 1H), 2.20 (ddt, J = 13.5, 8.1, 1.0 Hz, 1H), 1.95–1.65 (m, 5H), 1.52 (dq, J = 13.5, 7.4 
Hz, 1H), 0.89 (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 174.3, 136.8, 135.1, 
132.6, 128.7, 127.7, 126.5, 125.0, 117.8, 49.5, 47.9, 45.4, 43.4, 31.6, 28.9, 20.0, 8.9; IR 
(Neat Film, NaCl) 2938, 1631, 1487, 1448, 1352, 1282, 1196, 965, 912, 746 cm–1; 
HRMS (ESI+) m/z calc’d for C19H26NO [M+H]+: 284.2009, found 284.2019. 
 
 
3-allyl-1-benzyl-3-methylazepan-2-one (7m): 
Lactam 7m was prepared from S2b using General Procedure B.  Rf = 0.4 (33% ethyl 
acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.33–7.27 (m, 2H), 7.26–7.21 (m, 
3H), 5.94–5.72 (m, 1H), 5.12–5.07 (m, 1H), 5.06 (t, J = 1.2 Hz, 1H), 4.69 (d, J = 14.6 Hz, 
1H), 4.52 (d, J = 14.6 Hz, 1H), 3.42 (ddd, J = 15.2, 7.9, 4.0 Hz, 1H), 3.28 (ddd, J = 15.2, 
6.3, 3.9 Hz, 1H), 2.54–2.34 (m, 2H), 1.76–1.59 (m, 3H), 1.59–1.45 (m, 3H), 1.28 (s, 3H); 
13C NMR (CDCl3, 126 MHz) δ 177.5, 138.5, 135.0, 128.5, 128.1, 127.2, 117.7, 53.2, 
47.0, 46.3, 44.2, 34.9, 27.4, 26.2, 23.1; IR (Neat Film, NaCl) 2930, 1626, 1495, 1453, 
1359, 1244, 913, 746 cm–1; HRMS (ESI+) m/z calc’d for C17H24NO [M+H]+: 258.1852, 
found 258.1853. 
 
 
3-allyl-1-benzylazepan-2-one (7n): 
To a flame-dried round-bottom flask with a magnetic stir bar were added lactam S2b 
(1.00 g, 4.92 mmol, 1.00 equiv) and THF (26 mL).  The solution was stirred under 
nitrogen and cooled to –78 °C using a dry ice and acetone bath.  n-Butyllithium (2.5 M in 
hexane, 2.16 mL, 5.41 mmol, 1.10 equiv) was added dropwise by syringe, and the 
solution was allowed to stir at –78 °C for 1 hour.  Allyl bromide (510 µL, 5.90 mmol, 
1.20 equiv) was then added dropwise by syringe, and the solution was allowed to 
gradually warm to 23 °C and stir for 17 hours.  Upon completion (as determined by 
LCMS analysis), the reaction mixture was quenched by the addition of saturated aqueous 
ammonium chloride solution (100 mL), and the aqueous layer extracted with ethyl 
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 acetate (3 x 100 mL).  The combined organic layers were dried over magnesium sulfate, 
filtered, and concentrated in vacuo.  The crude residue was purified by silica gel column 
chromatography (20% ethyl aceate in hexanes) to provide lactam 7n as a colorless oil 
(838 mg, 70% yield).  Rf = 0.2 (25% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 7.34–7.28 (m, 2H), 7.27–7.22 (m, 3H), 5.88 (dddd, J = 17.1, 10.2, 7.9, 5.6 Hz, 
1H), 5.14–4.95 (m, 2H), 4.75 (d, J = 14.6 Hz, 1H), 4.45 (d, J = 14.6 Hz, 1H), 3.56–3.40 
(m, 1H), 3.17 (dddd, J = 15.3, 5.7, 2.1, 1.1 Hz, 1H), 2.66 (dtt, J = 14.3, 5.7, 1.5 Hz, 1H), 
2.59 (dtd, J = 10.4, 6.7, 6.0, 1.5 Hz, 1H), 2.12 (dtt, J = 14.0, 7.6, 1.1 Hz, 1H), 1.92–1.83 
(m, 1H), 1.76 (dtd, J = 13.9, 4.7, 1.3 Hz, 1H), 1.64 (ddt, J = 13.9, 5.3, 4.0 Hz, 1H), 1.51 
(dtt, J = 13.8, 12.4, 3.9 Hz, 1H), 1.34 (dddd, J = 13.8, 12.5, 10.5, 3.1 Hz, 1H), 1.28–1.12 
(m, 1H); 13C NMR (CDCl3, 126 MHz) δ 176.7, 138.2, 137.5, 128.6, 128.3, 127.3, 116.3, 
51.2, 48.1, 43.5, 36.8, 29.5, 29.3, 27.6; IR (Neat Film, NaCl) 2929, 1646, 1477, 1430, 
1358, 1263, 1217, 912, 736 cm–1; HRMS (ESI+) m/z calc’d for C16H22NO [M+H]+: 
244.1696, found 244.1708. 
 
 
3-allyl-1-benzyl-3-methylazepan-2-one (7o): 
Lactam 7o was prepared from S2c using General Procedure B.  Rf = 0.4 (20% ethyl 
acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.34–7.19 (m, 5H), 5.73 (dddd, J = 
16.8, 10.1, 8.3, 6.5 Hz, 1H), 5.16–4.97 (m, 2H), 4.47 (d, J = 14.6 Hz, 1H), 4.42 (d, J = 
14.6 Hz, 1H), 3.13–3.03 (m, 2H), 2.35 (ddt, J = 13.6, 6.5, 1.3 Hz, 1H), 2.19 (ddt, J = 
13.5, 8.3, 1.0 Hz, 1H), 1.97–1.86 (m, 1H), 1.86–1.77 (m, 1H), 1.64 (dq, J = 13.7, 7.5 Hz, 
1H), 1.52 (dq, J = 13.7, 7.4 Hz, 1H), 0.87 (t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 126 
MHz) δ 177.7, 136.8, 134.3, 128.7, 128.3, 127.6, 118.3, 48.2, 46.8, 43.9, 41.6, 30.0, 26.8, 
8.8; IR (Neat Film, NaCl) 3065, 2965, 1684, 1495, 1430, 1265, 1080, 1001, 916, 743 cm–
1; HRMS (ESI+) m/z calc’d for C16H22NO [M+H]+: 244.1696, found 244.1705. 
 
 
3-allyl-1-benzyl-3-methylpyrrolidin-2-one (7p): 
Lactam 7p was prepared from S2c using General Procedure B.  Rf = 0.4 (40% ethyl 
acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.35–7.19 (m, 5H), 5.74 (dddd, J = 
16.9, 10.1, 8.1, 6.7 Hz, 1H), 5.15–4.98 (m, 2H), 4.46 (d, J = 14.7 Hz, 1H), 4.42 (d, J = 
14.6 Hz, 1H), 3.19–3.01 (m, 2H), 2.33 (ddt, J = 13.6, 6.6, 1.3 Hz, 1H), 2.21 (ddt, J = 
13.7, 8.1, 1.0 Hz, 1H), 1.99 (ddd, J = 12.8, 8.2, 6.4 Hz, 1H), 1.69 (ddd, J = 12.8, 7.9, 5.5 
Hz, 1H), 1.16 (s, 3H); 13C NMR (CDCl3, 126 MHz) δ 178.7, 136.9, 134.3, 128.8, 128.3, 
127.7, 118.5, 47.0, 44.2, 43.6, 42.4, 30.6, 23.3; IR (Neat Film, NaCl) 2962, 1685, 1495, 
1430, 1290, 917, 739 cm–1; HRMS (ESI+) m/z calc’d for C15H20NO [M+H]+: 230.1539, 
found 230.1539. 
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3-allyl-1,3-dibenzylpyrrolidin-2-one (7q): 
Lactam 7q was prepared from S2c using General Procedure B.  Rf = 0.6 (33% ethyl 
acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.29–7.15 (m, 8H), 7.09–7.03 (m, 
2H), 5.79 (dddd, J = 16.7, 10.1, 8.5, 6.2 Hz, 1H), 5.18–5.07 (m, 2H), 4.47 (d, J = 14.7 
Hz, 1H), 4.16 (d, J = 14.7 Hz, 1H), 3.09 (d, J = 13.2 Hz, 1H), 2.86 (td, J = 9.2, 4.9 Hz, 
1H), 2.63 (d, J = 13.2 Hz, 1H), 2.52 (ddt, J = 13.6, 6.3, 1.4 Hz, 1H), 2.39–2.19 (m, 2H), 
1.98–1.78 (m, 2H); 13C NMR (CDCl3, 126 MHz) δ 177.0, 137.0, 136.4, 134.0, 130.3, 
128.6, 128.2, 128.2, 127.4, 126.6, 118.8, 49.5, 46.8, 43.8, 43.2, 42.8, 26.1; IR (Neat Film, 
NaCl) 2915, 1771, 1683, 1495, 1436, 1249, 917, 744 cm–1; HRMS (ESI+) m/z calc’d for 
C21H24NO [M+H]+: 306.1852, found 306.1857. 
 
 
3-allyl-1-benzylpyrrolidin-2-one (7o): 
To a flame-dried round-bottom flask with a magnetic stir bar were added 
diisopropylamine (479 µL, 3.42 mmol, 1.20 equiv) and THF (1.72 mL) by syringe.  The 
solution was stirred under nitrogen and cooled to 0 °C using an ice water bath.  n-
Butyllithium (2.5 M in hexane, 1.36 mL, 3.39 mmol, 1.19 equiv) was added rapidly 
dropwise by syringe, and the solution was allowed to stir at 0 °C for 20 minutes.  
Meanwhile, lactam S2c (500 mg, 2.85 mmol, 1.00 equiv) was dissolved in THF (9 mL) in 
a flame-dried round-bottom flask under nitrogen and cooled to 0 °C using an ice water 
bath.  The freshly prepared LDA solution was transferred to the lactam solution rapidly 
dropwise via syringe, and the mixture was allowed to stir at 0 °C for 45 minutes.  The 
solution was then cooled to –78 °C using a dry ice and acetone bath, and allyl bromide 
(321 µL, 3.71 mmol, 1.30 equiv) was added dropwise by syringe.  The flask was placed 
in an ice water bath, allowed to gradually warm to 23 °C, and stirred for 20 hours.  Upon 
completion (as determined by TLC analysis), the reaction mixture was quenched by the 
addition of saturated aqueous ammonium chloride solution (100 mL), and the aqueous 
layer extracted with chloroform (3 x 100 mL).  The combined organic layers were 
washed with 1 M aqueous hydrochloric acid (2 x 100 mL), water (1 x 100 mL), brine (1 x 
100 mL), dried over sodium sulfate, and concentrated in vacuo.  The crude residue was 
purified by silica gel column chromatography (20% ethyl aceate in hexanes) to provide 
lactam 7o as a colorless oil (509 mg, 83% yield).  Rf = 0.3 (20% ethyl acetate in 
hexanes); characterization data match those reported in the literature.[ 9 ] 
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3-allyl-1-benzyl-3-(but-3-en-1-yl)piperidin-2-one (7s): 
Lactam 7s was prepared from S2a using General Procedure B.  Rf = 0.6 (33% ethyl 
acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.35–7.26 (m, 2H), 7.26–7.21 (m, 
3H), 5.94–5.45 (m, 2H), 5.17–4.87 (m, 4H), 4.68–4.46 (m, 2H), 3.24–3.10 (m, 2H), 2.58 
(ddt, J = 13.5, 6.8, 1.3 Hz, 1H), 2.26 (ddt, J = 13.5, 8.0, 1.0 Hz, 1H), 2.19–2.00 (m, 2H), 
1.88 (ddd, J = 13.4, 11.9, 5.0 Hz, 1H), 1.82–1.65 (m, 4H), 1.65 (s, 1H); 13C NMR 
(CDCl3, 126 MHz) δ 174.2, 138.9, 137.7, 134.7, 128.6, 128.2, 127.4, 118.1, 114.5, 50.7, 
47.8, 44.9, 43.6, 38.2, 29.6, 28.9, 19.8; IR (Neat Film, NaCl) 3073, 2940, 1633, 1495, 
1453, 1352, 1193, 998, 911, 701 cm–1; HRMS (ESI+) m/z calc’d for C19H26NO [M+H]+: 
284.2009, found 284.2014. 
 
 
1,3-diallyl-3-ethylpiperidin-2-one (7t): 
To a flame-dried round-bottom flask with a magnetic stir bar were added lactam 7h (500 
mg, 3.35 mmol, 1.00 equiv) and THF (17 mL).  The flask was capped with a rubber 
septum, put under an argon atmosphere, and cooled to 0 °C using an ice water bath.  
Sodium hydride (60% dispersion in mineral oil, 268 mg, 6.70 mmol, 2.00 equiv) was 
then added in one portion, and the suspension was allowed to warm to 23 °C and stir for 
2 hours.  The suspension was then cooled to 0 °C using an ice water bath, and allyl 
bromide (320 µL, 3.69 mmol, 1.10 equiv) was added by syringe.  The suspension was 
allowed to warm to 23 °C and stir for 13 hours.  Upon completion (as determined by TLC 
analysis), the reaction mixture was diluted with water (100 mL) and extracted with ethyl 
acetate (3 x 100 mL).  The combined organic layers were washed with brine (1 x 100 
mL), dried over sodium sulfate, filtered, and concentrated in vacuo.  The crude residue 
was purified by silica gel column chromatography (10% ethyl acetate in hexanes) to 
provide lactam 7t as a colorless oil (690 mg, >99% yield).  Rf = 0.4 (25% ethyl acetate in 
hexanes); 1H NMR (CDCl3, 500 MHz) δ 5.78–5.63 (m, 2H), 5.13–5.05 (m, 2H), 5.03 
(ddt, J = 4.6, 2.3, 1.3 Hz, 1H), 5.00 (h, J = 1.1 Hz, 1H), 3.94 (dq, J = 5.9, 1.4 Hz, 2H), 
3.30–2.98 (m, 2H), 2.47 (ddt, J = 13.5, 6.6, 1.3 Hz, 1H), 2.14 (ddt, J = 13.5, 8.1, 1.0 Hz, 
1H), 1.89–1.58 (m, 5H), 1.45 (dq, J = 13.5, 7.4 Hz, 1H), 0.83 (t, J = 7.4 Hz, 3H); 13C 
NMR (CDCl3, 126 MHz) δ 174.1, 135.0, 133.2, 117.7, 116.8, 49.9, 47.8, 45.2, 43.3, 31.5, 
28.9, 19.9, 8.8; IR (Neat Film, NaCl) 3075, 2939, 1635, 1488, 1441, 1356, 1269, 1200, 
998, 914 cm–1; HRMS (ESI+) m/z calc’d for C13H22NO [M+H]+: 208.1696, found 
208.1705. 
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diethyl 2-allyl-2-methylmalonate (S7): 
To a flame-dried round-bottom flask with a magnetic stir bar were added sodium hydride 
(60% dispersion in mineral oil, 2.20 g, 55.0 mmol, 1.10 equiv) and THF (200 mL).  The 
flask was capped with a rubber septum, put under an argon atmosphere, and cooled to 0 
°C using an ice water bath.  Diethyl methylmalonate (S6, 8.52 mL, 50.0 mmol, 1.00 
equiv) was added dropwise by syringe, and the suspension was stirred at 0 °C for 1 hour.  
Allyl bromide (5.19 mL, 60.0 mmol, 1.20 equiv) was then added dropwise by syringe, 
and the suspension was allowed to warm to 23 °C and stir for 15 hours.  Upon 
completion (as determined by TLC analysis), the reaction mixture was diluted with ethyl 
acetate (400 mL) and extracted with water  (1 x 300 mL).  The organic layer was 
concentrated, and the crude residue was purified by silica gel column chromatography 
(5% ethyl acetate in hexanes) to provide malonate S7 as a colorless oil (10.30 g, 96% 
yield).  Rf = 0.4 (25% ethyl acetate in hexanes); characterization data match those 
reported in the literature.10 
 
 
ethyl 2-(hydroxymethyl)-2-methylpent-4-enoate (S8): 
To a flame-dried round-bottom flask with a magnetic stir bar were added malonate S7 
(4.00 g, 18.7 mmol, 1.00 equiv) and THF (75 mL).  The flask was capped with a rubber 
septum and put under an argon atmosphere.  A solution of lithium tri-tert-
butoxyaluminum hydride (10.44 g, 41.1 mmol, 2.20 equiv) in THF (41 mL) was added, 
and the resulting mixture was heated to 65 °C for 26 hours.  At this point, although TLC 
analysis did not show full consumption of S7, the mixture was quenched with 200 mL 
10% aqueous sodium bisulfate.  The mixture was extracted with ethyl acetate (3 x 200 
mL), and the combined organic layers were dried over magnesium sulfate, filtered, and 
concentrated in vacuo.  The crude residue was purified by silica gel column 
chromatography (20% ethyl acetate in hexanes) to provide alcohol S8 as a colorless oil 
(2.60 g, 81% yield).  Rf = 0.3 (25% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 5.90–5.29 (m, 1H), 5.10 (ddt, J = 6.6, 2.1, 1.2 Hz, 1H), 5.07 (q, J = 1.2 Hz, 1H), 
4.17 (qt, J = 7.1, 1.3 Hz, 2H), 3.68 (dd, J = 11.4, 1.0 Hz, 1H), 3.53 (dd, J = 11.3, 1.1 Hz, 
1H), 2.39–2.32 (bs, 1H), 2.34 (ddt, J = 7.5, 2.3, 1.1 Hz, 2H), 1.28 (td, J = 7.1, 1.1 Hz, 
3H), 1.17 (d, J = 1.0 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 176.8, 133.4, 118.6, 67.9, 
60.9, 47.6, 40.1, 19.6, 14.3; IR (Neat Film, NaCl) 3461, 3078, 2980, 1722, 1641, 1467, 
1369, 1324, 1218, 1146, 1044, 918, 862 cm–1; HRMS (FAB+) m/z calc’d for C9H17O3 
[M+H]+: 173.1178, found 173.1177. 
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ethyl 2-formyl-2-methylpent-4-enoate (S9): 
To a flame-dried round-bottom flask with a magnetic stir bar were added oxalyl chloride  
(1.11 mL, 13.1 mmol, 1.00 equiv) and dichloromethane (90 mL).  The flask was capped 
with a rubber septum, put under an argon atmosphere, and cooled to –78 °C using a dry 
ice and acetone bath.  DMSO (1.86 mL, 26.24 mmol, 2.00 equiv) was added dropwise by 
syringe, and the solution was stirred at –78 °C for 1 hour.  A solution of alcohol S8 (2.26 
g, 13.1 mmol, 1.00 equiv) in dichloromethane (45 mL) was added dropwise by syringe, 
and the solution was stirred at–78 °C for 45 minutes.  Triethylamine (9.14 mL, 65.6 
mmol, 5.00 equiv) was added dropwise by syringe.  The solution was stirred at –78 °C 
for 10 minutes, warmed to 0 °C over approximately 30 minutes, and allowed to warm to 
23 °C over approximately 1 hour.  Upon completion (as determined by TLC analysis), 
the reaction was quenched with 2 M aqueous hydrochloric acid (200 mL).  The organic 
layer was washed with saturated aqueous sodium bicarbonate (200 mL), dried over 
magnesium sulfate, filtered, and concentrated in vacuo.  The crude residue was purified 
by silica gel column chromatography (10% ethyl acetate in hexanes) to provide aldehyde 
S9 as a colorless oil (1.87 g, 88% yield).  Rf = 0.7 (25% ethyl acetate in hexanes); 1H 
NMR (CDCl3, 500 MHz) δ 9.61 (s, 1H), 5.61 (ddt, J = 16.8, 10.2, 7.4 Hz, 1H), 5.08–5.04 
(m, 1H), 5.04–5.01 (m, 1H), 4.14 (qd, J = 7.1, 1.0 Hz, 2H), 2.60–2.49 (m, 1H), 2.48–2.38 
(m, 1H), 1.23 (s, 3H), 1.21 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 199.1, 
171.6, 131.8, 119.4, 61.4, 57.3, 38.5, 16.7, 14.1; IR (Neat Film, NaCl) 3450, 3081, 2983, 
2730, 1722, 1641, 1457, 1374, 1299, 1233, 1150, 1021, 924, 858 cm–1; HRMS (FAB+) 
m/z calc’d for C9H15O3 [M+H]+: 171.1021, found 171.1021. 
 
 
ethyl 2-((benzylamino)methyl)-2-methylpent-4-enoate (S10): 
To a round-bottom flask with a magnetic stir bar were added aldehyde S9 (1.74 g, 10.2 
mmol, 1.00 equiv), toluene (16 mL), and benzylamine (1.17 mL, 10.7 mmol, 1.05 equiv).  
The solution was refluxed for 10 hours using a Dean–Stark trap.  The solution was then 
allowed to cool to 23 °C and concentrated in vacuo.  The residue was dissolved in ethanol 
(31 mL) and cooled to 0 °C using an ice water bath.  Sodium borohydride (772 mg, 20.4 
mmol, 2.00 equiv relative to S9) was added, and the mixture was stirred at 0 °C for 3 
hours.  Upon completion (as determined by TLC analysis), the mixture was diluted with 
water (200 mL) and extracted with ethyl acetate (3 x 200 mL).  The combined organic 
layers were dried over magnesium sulfate, filtered, and concentrated in vacuo.  The crude 
residue was purified by silica gel column chromatography (10% ethyl acetate in hexanes) 
to provide amine S10 as a colorless oil (1.47 g, 55% yield).  Rf = 0.3 (10% ethyl acetate 
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 in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.34–7.30 (m, 4H), 7.26–7.23 (m, 1H), 5.72 
(ddt, J = 16.6, 10.4, 7.4 Hz, 1H), 5.06 (ddt, J = 7.9, 2.1, 1.2 Hz, 1H), 5.03 (t, J = 1.2 Hz, 
1H), 4.14 (q, J = 7.1 Hz, 2H), 3.79 (s, 2H), 2.78 (d, J = 11.8 Hz, 1H), 2.61 (d, J = 11.8 
Hz, 1H), 2.39 (ddt, J = 13.7, 7.2, 1.2 Hz, 1H), 2.28 (ddt, J = 13.6, 7.6, 1.1 Hz, 1H), 1.47 
(d, J = 79.2 Hz, 1H), 1.25 (t, J = 7.1 Hz, 3H), 1.18 (s, 3H); 13C NMR (CDCl3, 126 MHz) 
δ 176.6, 140.7, 134.0, 128.4, 128.1, 126.9, 118.1, 60.5, 56.1, 54.4, 47.1, 41.4, 20.7, 14.4; 
IR (Neat Film, NaCl) 2978, 1727, 1640, 1453, 1213, 1145, 1028, 917, 737, 698 cm–1; 
HRMS (ESI+) m/z calc’d for C16H24NO2 [M+H]+: 262.1802, found 262.1812. 
 
 
3-allyl-1-benzyl-3-methylazetidin-2-one (7u): 
The conditions for this transformation were adapted from a known procedure.  To a 
flame-dried round-bottom flask with a magnetic stir bar were added amine S10 (500 mg, 
1.91 mmol, 1.00 equiv) and THF (5 mL).  The flask was capped with a rubber septum, 
put under an argon atmosphere, and cooled to 0 °C using an ice water bath.  
Ethylmagnesium bromide (1 M in THF, 1.91 mL, 1.91 mmol, 1.00 equiv) was added 
dropwise, and the solution was stirred at 0 °C for 2 hours.  At this point, although TLC 
analysis did not show full consumption of S10, the mixture was quenched with 100 mL 
ice-cold saturated aqueous ammonium chloride.  The aqueous solution was extracted with 
ether (1 x 100 mL) and dichloromethane (2 x 100 mL).  The combined organic layers 
were dried over magnesium sulfate, filtered, and concentrated in vacuo.  The crude 
residue was purified by silica gel column chromatography (10% ethyl acetate in hexanes) 
to provide lactam 7u as a colorless oil (303 mg, 74% yield).  Rf = 0.4 (25% ethyl acetate 
in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.36–7.26 (m, 3H), 7.22 (ddt, J = 7.4, 1.3, 
0.6 Hz, 2H), 5.77 (dddd, J = 16.9, 10.1, 7.8, 6.7 Hz, 1H), 5.15–5.04 (m, 2H), 4.44–4.28 
(m, 2H), 3.04 (d, J = 5.3 Hz, 1H), 2.83 (d, J = 5.3 Hz, 1H), 2.39 (ddt, J = 14.0, 6.7, 1.3 
Hz, 1H), 2.35 (s, 1H), 1.30 (s, 3H).; 13C NMR (CDCl3, 126 MHz) δ 173.0, 135.8, 133.5, 
128.8, 128.2, 127.7, 118.5, 54.2, 50.8, 45.7. 39.1, 19.5; IR (Neat Film, NaCl) 2961, 1748, 
1496, 1454, 1402, 1354, 998, 920, 738, 701 cm–1; HRMS (ESI+) m/z calc’d for 
C14H18NO [M+H]+: 216.1383, found 216.1392. 
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 Procedures for Unsuccessful Allylic Oxidations 
 
 
Allylic acetates 8a and 8h were prepared from 7a and 7h following a known 
procedure.[11]  To a round-bottom flask with a magnetic stir bar were added, in order, 
sodium acetate (3.5 mg, 0.043 mmol, 0.20 equiv), palladium(II) acetate (2.4 mg, 0.011 
mmol, 0.05 equiv), diazefluorenone ligand (1.9 mg, 0.011 mmol, 0.05 equiv), dioxane 
(600 µL), and acetic acid (190 µL).  The appropriate lactam substrate (7a or 7h, 0.21 
mmol, 1.00 equiv) was added, and the flask was capped with a rubber septum.  The 
solution was stirred vigorously while oxygen was bubbled through for 15 minutes.  The 
solution was then stirred at 60 °C under an oxygen atmosphere for 41 hours.  TLC 
analysis throughout this time showed little conversion of the starting material.  After 41 
hours, the reaction mixture was filtered through a plug of silica gel, rinsing with ethyl 
acetate, and concentrated to give the crude residue.  In the case of either lactam substrate, 
NMR and LCMS analysis showed small amounts of the corresponding allylic acetate 
product (8a or 8h).  Characterization data for 8a and 8h are provided below. 
 
 
To a 1 dram screw-top vial with a magnetic stir bar were added lactam 7h (25 mg, 0.15 
mmol, 1.00 equiv) and dioxane (1.5 mL). Selenium dioxide (83 mg, 5.00 equiv) was 
added and the reaction mixture was stirred at 80 ºC for 2h.  At this time, TLC analysis 
showed only baseline material, and the mixture was filtered through a plug of silica gel, 
rinsing with ethyl acetate.  The filtrate was concentrated and NMR and LCMS analysis 
showed complete decomposition of the starting material. 
 
 
The conditions for this transformation were adapted from a known procedure.[12]  To a 1 
dram screw-top vial with a magnetic stir bar were added lactam 7h (27 mg, 0.16 mmol, 
1.00 equiv) and dichlomethane (1.5 mL).  Selenium dioxide (9 mg, 0.08 mmol, 0.50 
equiv) and TBHP (5 M in decane, 160 µL, 0.80 mmol, 5.00 equiv) were added and the 
reaction mixture was stirred at 23 °C for 5 hours.  TLC analysis throughout this time 
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 showed no conversion of the starting material.  After 5 hours, the reaction mixture was 
filtered through a plug of silica gel, rinsing with ethyl acetate, and concentrated to give 
the crude residue.  NMR and LCMS analysis showed only starting material 7h and trace 
impurities. 
 
 
To a 1 dram screw-top vial with a magnetic stir bar were added lactam 7a (10 mg, 0.039 
mmol, 1.00 equiv) and carbon tetrachloride (2 mL).  Tetraphenylporphyrin (6 mg, 0.20 
mmol, 5 mM in reaction solution) was added, the vial was capped with a septum, and 
oxygen was bubbled through the stirring solution for 2 minutes.  The vial was cooled to 0 
°C using an ice water bath, and a 500 W halogen floodlight was placed at a distance d = 
10 cm from the vial.  The solution was irradiated and allowed to gradually warm to 23 °C 
over a period of 2 hours, and was further irradiated at 23 °C for an additional 12 hours.  
TLC analysis throughout this time showed no reactivity.  After 14 hours total reaction 
time, the mixture was filtered through a plug of silica gel, rinsing with ethyl acetate.  The 
filtrate was concentrated, and NMR and LCMS analysis showed only starting material 7a 
and tetraphenylporphyrin. 
 
 
3-allyl-1-benzyl-3-ethylpiperidine-2,6-dione (5): 
Imide 5 was prepared from 7a following a known procedure.[13]  Lactam 7a (20 mg, 
0.078 mmol, 1.00 equiv) was dissolved in 3.1 mL acetic acid in a 20 mL vial with a stir 
bar and heated to 77 °C.  A solution of chromium(VI) oxide (31 mg, 0.31 mmol, 4.00 
equiv) in acetic acid (1.6 mL) was added dropwise by pipette.  The vial was sealed with a 
Teflon-lined cap and stirred at 77 °C for 1 hour.  LCMS analysis at 1 hour showed full 
conversion of the starting material.  The mixture was cooled to 23 °C, and filtered 
through a plug of silica gel, rinsing with ethyl acetate.  The filtrate was diluted with 
heptanes and concentrated.  The crude residue was purified by silica gel column 
chromatography (20% ethyl aceate in hexanes) to provide imide 5 as a colorless oil (6.6 
mg, 31% yield).  Rf = 0.6 (25% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 
7.34–7.26 (m, 4H), 7.25–7.20 (m, 1H), 5.66 (dddd, J = 17.0, 10.2, 7.8, 6.9 Hz, 1H), 5.13–
5.00 (m, 2H), 4.95 (s, 2H), 2.79–2.63 (m, 2H), 2.49 (ddt, J = 13.8, 6.9, 1.3 Hz, 1H), 2.29 
(ddt, J = 13.9, 7.8, 1.1 Hz, 1H), 1.92–1.77 (m, 2H), 1.72 (dq, J = 14.0, 7.5 Hz, 1H), 1.68–
1.58 (m, 1H), 0.84 (t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 176.5, 172.2, 
137.7, 133.0, 128.7, 128.5, 127.4, 119.3, 45.2, 43.2, 40.2, 29.3, 28.7, 24.8, 8.3; IR (Neat 
Film, NaCl) 2967, 1722, 1676, 1455, 1345, 1164 cm–1; HRMS (ESI+) m/z calc’d for 
C17H22NO2 [M+H]+: 272.1645, found 272.1632. 
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The conditions for this transformation were adapted from a known procedure.[14]  To an 
oven-dried 1 dram screw-top vial with a magnetic stir bar were added, in order, lactam 7a 
(35 mg, 0.14 mmol, 1.00 equiv) potassium carbonate (5 mg, 0.036 mmol, 0.26 equiv), 
and dichloromethane (750 µL).  Palladium hydroxide on carbon (20 wt. %, 11 mg) and 
tert-butyl hydroperoxide (5.0 M in decane, 137 µL, 0.69 mmol, 5.00 equiv) were added.  
The vial was sealed with a Teflon-lined cap and the reaction mixture was stirred at 23 °C 
for 48 hours.  TLC analysis throughout this time showed very little conversion of the 
starting material.  After 48 hours, the mixture was filtered through Celite, rinsing first 
with dichloromethane and later with ethyl acetate.  The filtrate was concentrated and 
NMR and LCMS analysis showed starting material 7a with trace impurities. 
 
 
The conditions for this transformation were adapted from a known procedure.[15] To a 1 
dram screw-top vial with a magnetic stir bar were added lactam 7h (17 mg, 0.10 mmol, 
1.00 equiv) and benzene (1 mL).  Copper(I) bromide (16 mg, 0.11 mmol, 1.10 equiv) and 
tert-butyl peroxybenzoate (110 µL, 0.60 mmol, 6.00 equiv) were added and the reaction 
mixture was heated to 80 °C and stirred for 5 hours.  TLC and LCMS analysis throughout 
this time showed no conversion of the starting material.  After 5 hours, the mixture was 
filtered through a plug of silica gel, rinsing with ethyl acetate.  The filtrate was 
concentrated and NMR and LCMS analysis showed only starting material 7h. 
 
 
The conditions for this reaction were adapted from a known procedure.[16]  To a round-
bottom flask with a magnetic stir bar were added, in order, palladium(II) acetate (5.5 mg, 
0.025 mmol, 0.10 equiv), benzoquinone (53 mg, 0.50 mmol, 2.00 equiv), and activated 4 
Å molecular sieves (53 mg).  DMSO (740 µL), lactam 7h (41 mg, 0.25 mmol, 1.00 
equiv), and acetic acid (740 µL) were added.  The vial was sealed with a Teflon-lined cap 
and heated to 40 °C for 15 hours.  TLC analysis throughout this time showed no 
conversion of the starting material.  After 15 hours, the reaction mixture was quenched 
with saturated aqueous ammonium chloride (10 mL) and extracted with dichloromethane 
(3 x 10 mL).  The combined organic layers were washed with water (1 x 10 mL), dried 
over sodium sulfate, filtered, and concentrated in vacuo.  NMR and LCMS analysis of the 
crude product showed only starting material 7h and trace impurities. 
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 Allylic Acetate Characterization Data 
 
 
(E)-3-(1-benzyl-3-ethyl-2-oxopiperidin-3-yl)allyl acetate (8a): 
Acetate 8a was prepared from 7a using General Procedure D.  56% isolated yield, 63% 
combined yield with 9a.  Rf = 0.3 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 7.34–7.28 (m, 2H), 7.28–7.20 (m, 3H), 5.88 (dt, J = 16.0, 1.3 Hz, 1H), 5.61 (dt, J 
= 15.9, 6.2 Hz, 1H), 4.65 (d, J = 14.5 Hz, 1H), 4.59–4.54 (m, 2H), 4.51 (d, J = 14.6 Hz, 
1H), 3.26–3.04 (m, 2H), 2.06 (s, 3H), 1.95–1.84 (m, 1H), 1.84–1.70 (m, 4H), 1.70–1.59 
(m, 1H), 0.85 (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 172.7, 171.0, 139.5, 
137.6, 128.7, 128.1, 127.4, 123.7, 65.2, 50.7, 48.5, 47.8, 31.9, 29.1, 21.2, 19.3, 8.6; IR 
(Neat Film, NaCl) 2939, 1738, 1634, 1495, 1453, 1361, 1231, 1028, 969, 736 cm–1; 
HRMS (ESI+) m/z calc’d for C19H26NO3 [M+H]+: 316.1907, found 316.1913. 
 
 
(E)-3-(1-benzyl-3-methyl-2-oxopiperidin-3-yl)allyl acetate (8b): 
Acetate 8b was prepared from 7b using General Procedure D.  67% isolated yield, 74% 
combined yield with 9b.  Rf = 0.2 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 7.35–7.26 (m, 3H), 7.26–7.20 (m, 2H), 5.91 (dt, J = 15.8, 1.3 Hz, 1H), 5.63 (dt, J 
= 15.8, 6.2 Hz, 1H), 4.62 (d, J = 14.6 Hz, 1H), 4.56 (dt, J = 6.3, 1.5 Hz, 2H), 4.52 (d, J = 
14.5 Hz, 1H), 3.29–3.06 (m, 2H), 2.06 (s, 3H), 1.95–1.86 (m, 1H), 1.86–1.78 (m, 1H), 
1.78–1.69 (m, 2H), 1.36 (s, 3H); 13C NMR (CDCl3, 126 MHz) δ 173.1, 170.9, 140.5, 
137.6, 128.7, 128.1, 127.4, 123.2, 65.1, 50.6, 47.9, 44.7, 34.2, 26.6, 21.2, 19.5; IR (Neat 
Film, NaCl) 2936, 1738, 1634, 1489, 1453, 1361, 1232, 1028, 976, 736 cm–1; HRMS 
(ESI+) m/z calc’d for C18H24NO3 [M+H]+: 302.1751, found 302.1755. 
 
 
(E)-3-(1,3-dibenzyl-2-oxopiperidin-3-yl)allyl acetate (8c): 
Acetate 8c was prepared from 7c using General Procedure D.  54% isolated yield, 62% 
combined yield with 9c.  Rf = 0.3 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 7.30–7.26 (m, 2H), 7.26–7.12 (m, 8H), 5.88 (dt, J = 15.9, 1.4 Hz, 1H), 5.63 (dt, J 
= 15.9, 6.1 Hz, 1H), 4.76 (d, J = 14.6 Hz, 1H), 4.68–4.52 (m, 2H), 4.43 (d, J = 14.6 Hz, 
BnN
O
Et
7a
BnN
O
Et
8a
OAc
BnN
O
Me
7b
BnN
O
Me
8b
OAc
BnN
O
Bn
7c
BnN
O
Bn
8c
OAc
Xing, O'Connor, and Stoltz Supporting Information
S24
 1H), 3.38 (d, J = 13.2 Hz, 1H), 3.16–2.99 (m, 2H), 2.79 (d, J = 13.2 Hz, 1H), 2.08 (s, 
3H), 1.87–1.53 (m, 4H); 13C NMR (CDCl3, 126 MHz) δ 171.8, 171.0, 139.4, 137.4, 
137.3, 131.2, 128.6, 128.1, 128.0, 127.4, 126.6, 124.4, 65.0, 50.9, 49.8, 47.9, 45.0, 29.8, 
21.2, 19.2; IR (Neat Film, NaCl) 2940, 1738, 1634, 1495, 1453, 1360, 1233, 1193, 1028, 
979, 743 cm–1; HRMS (ESI+) m/z calc’d for C24H28NO3 [M+H]+: 378.2064, found 
378.2067. 
 
 
(E)-3-(1-benzyl-2-oxo-3-propylpiperidin-3-yl)allyl acetate (8d): 
Acetate 8d was prepared from 7d using General Procedure D.  58% isolated yield, 66% 
combined yield with 9d.  Rf = 0.3 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 7.34–7.26 (m, 3H), 7.26–7.20 (m, 2H), 5.89 (dt, J = 16.0, 1.4 Hz, 1H), 5.61 (dt, J 
= 16.0, 6.2 Hz, 1H), 4.62 (d, J = 14.5 Hz, 1H), 4.57 (dt, J = 6.3, 1.5 Hz, 2H), 4.53 (d, J = 
14.6 Hz, 1H), 3.30–3.01 (m, 2H), 2.06 (s, 3H), 1.89–1.76 (m, 4H), 1.76–1.69 (m, 1H), 
1.61 (ddd, J = 13.4, 12.3, 4.4 Hz, 1H), 1.39–1.14 (m, 2H), 0.91 (t, J = 7.3 Hz, 3H); 13C 
NMR (CDCl3, 126 MHz) δ 172.7, 171.0, 139.8, 137.6, 128.7, 128.2, 127.4, 123.5, 65.3, 
50.7, 48.4, 47.8, 41.6, 29.9, 21.2, 19.4, 17.5, 14.7; IR (Neat Film, NaCl) 2955, 1739, 
1635, 1495, 1453, 1360, 1230, 1027, 979, 736 cm–1; HRMS (ESI+) m/z calc’d for 
C20H28NO3 [M+H]+: 330.2064, found 330.2067. 
 
 
(E)-3-(1-benzyl-3-(2-methoxyethyl)-2-oxopiperidin-3-yl)allyl acetate (8e): 
Acetate 8e was prepared from 7e using General Procedure D.  55% isolated yield, 61% 
combined yield with 9e.  Rf = 0.2 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 7.40–7.31 (m, 3H), 7.30–7.25 (m, 2H), 5.91 (dt, J = 15.9, 1.3 Hz, 1H), 5.68 (dt, J 
= 15.9, 6.2 Hz, 1H), 4.69 (d, J = 14.5 Hz, 1H), 4.67–4.59 (m, 2H), 4.57 (d, J = 14.6 Hz, 
1H), 3.57–3.45 (m, 2H), 3.34 (s, 3H), 3.30–3.17 (m, 2H), 2.24–2.14 (m, 1H), 2.12 (s, 
3H), 2.02–1.71 (m, 5H); 13C NMR (CDCl3, 126 MHz) δ 172.0, 170.8, 139.0, 137.4, 
128.6, 128.0, 127.3, 124.0, 69.5, 64.9, 58.5, 50.6, 47.7, 47.3, 38.4, 30.8, 21.0, 19.2; IR 
(Neat Film, NaCl) 2936, 2872, 1738, 1634, 1489, 1453, 1360, 1240, 1196, 1113, 1028, 
972, 736 cm–1; HRMS (ESI+) m/z calc’d for C20H28NO4 [M+H]+: 346.2013, found 
346.2023. 
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(E)-3-(1-benzyl-2-oxo-3-phenylpiperidin-3-yl)allyl acetate (8f): 
Acetate 8f was prepared from 7f using General Procedure D.  62% isolated yield, 70% 
combined yield with 9f.  Rf = 0.8 (50% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 7.38–7.27 (m, 8H), 7.25–7.18 (m, 2H), 6.38 (dt, J = 16.0, 1.4 Hz, 1H), 5.69 (dt, J 
= 16.0, 6.2 Hz, 1H), 4.82 (d, J = 14.4 Hz, 1H), 4.64 (dt, J = 6.2, 1.2 Hz, 2H), 4.54 (d, J = 
14.4 Hz, 1H), 3.34–3.12 (m, 2H), 2.32–2.13 (m, 2H), 2.08 (s, 3H), 1.83–1.71 (m, 1H), 
1.71–1.59 (m, 1H); 13C NMR (CDCl3, 126 MHz) δ 171.4, 171.0, 143.3, 139.3, 137.4, 
128.8, 128.6, 128.5, 127.6, 127.5, 126.9, 123.7, 65.2, 53.9, 51.0, 47.6, 33.3, 21.2, 18.9; 
IR (Neat Film, NaCl) 2934, 1737, 1636, 1494, 1445, 1352, 1231, 1195, 1027, 761, 700 
cm–1; HRMS (ESI+) m/z calc’d for C23H26NO3 [M+H]+: 364.1906, found 364.1901. 
 
 
(E)-3-(3-ethyl-1-methyl-2-oxopiperidin-3-yl)allyl acetate (8g): 
Acetate 8g was prepared from 7g using General Procedure D.  59% isolated yield, 65% 
combined yield with 9g.  Rf = 0.1 (50% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 5.83 (dt, J = 16.0, 1.4 Hz, 1H), 5.55 (dt, J = 16.0, 6.2 Hz, 1H), 4.70–4.32 (m, 
2H), 3.35–3.26 (m, 1H), 3.25–3.15 (m, 1H), 2.92 (s, 3H), 2.05 (s, 3H), 1.91–1.76 (m, 
5H), 1.64 (dq, J = 13.7, 7.5 Hz, 1H), 0.80 (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 126 
MHz) δ 172.8, 171.0, 139.4, 123.5, 65.2, 50.5, 48.3, 35.3, 31.7, 29.1, 21.2, 19.3, 8.5; IR 
(Neat Film, NaCl) 2940, 1739, 1636, 1500, 1446, 1362, 1242, 1026, 981 cm–1; HRMS 
(ESI+) m/z calc’d for C13H21NO3 [M+H]+: 240.1594, found 240.1598. 
 
 
(E)-3-(3-ethyl-2-oxopiperidin-3-yl)allyl acetate (8h): 
Acetate 8h was prepared from 7h using General Procedure D.  51% isolated yield, 56% 
combined yield with 9h.  Rf = 0.1 (67% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 6.00 (s, 1H), 5.82 (dt, J = 16.0, 1.3 Hz, 1H), 5.62 (dt, J = 15.9, 6.2 Hz, 1H), 
4.68–4.41 (m, 2H), 3.28 (qd, J = 4.2, 3.6, 1.7 Hz, 2H), 2.05 (s, 3H), 1.96–1.70 (m, 5H), 
1.63 (dq, J = 13.7, 7.5 Hz, 1H), 0.85 (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 
175.0, 171.0, 138.9, 123.9, 65.1, 48.2, 42.8, 31.4, 29.0, 21.2, 19.2, 8.5; IR (Neat Film, 
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 NaCl) 3203, 2941, 1740, 1657, 1490, 1361, 1231, 1027, 980 cm–1; HRMS (ESI+) m/z 
calc’d for C12H20NO3 [M+H]+: 226.1438, found 226.1430. 
 
 
(E)-3-(1-benzyl-2-oxopiperidin-3-yl)allyl acetate (8i): 
Acetate 8i was prepared from 7i using General Procedure D.  61% isolated yield.  Rf = 
0.2 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.37–7.19 (m, 5H), 
6.06 (dd, J = 15.7, 6.4 Hz, 1H), 5.71 (dt, J = 15.2, 6.3 Hz, 1H), 4.78–4.38 (m, 4H), 3.22 
(t, J = 5.9 Hz, 2H), 3.16 (q, J = 7.0 Hz, 1H), 2.07 (d, J = 1.6 Hz, 3H), 2.06–1.70 (m, 4H); 
13C NMR (CDCl3, 126 MHz) δ 171.0, 170.3, 137.3, 134.2, 128.7, 128.3, 127.5, 125.6, 
65.1 50.5, 47.5, 44.7, 27.2, 21.4, 21.2; IR (Neat Film, NaCl) 3225, 2936, 1738, 1618, 
1494, 1453, 1361, 1234, 1028, 737 cm–1; HRMS (ESI+) m/z calc’d for C17H22NO3 
[M+H]+: 288.1594, found 288.1607. 
 
 
(E)-3-(3-ethyl-1-(4-methoxyphenyl)-2-oxopiperidin-3-yl)allyl acetate (8j): 
Acetate 8j was prepared from 7j using General Procedure D.  54% isolated yield, 61% 
combined yield with 9j.  Rf = 0.2 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 7.15–7.06 (m, 2H), 6.96–6.84 (m, 2H), 5.91 (dt, J = 15.9, 1.3 Hz, 1H), 5.68 (dt, J 
= 15.9, 6.2 Hz, 1H), 4.71–4.52 (m, 2H), 3.80 (s, 3H), 3.70–3.48 (m, 2H), 2.08 (s, 3H), 
2.04–1.82 (m, 5H), 1.69 (dq, J = 13.6, 7.4 Hz, 1H), 0.90 (t, J = 7.4 Hz, 3H); 13C NMR 
(CDCl3, 126 MHz) δ 173.1, 171.0, 158.2, 139.5, 136.7, 127.6, 123.7, 114.5, 65.3, 55.6, 
52.5, 48.8, 32.0, 29.4, 21.2, 20.0, 8.7; IR (Neat Film, NaCl) 2939, 1739, 1645, 1607, 
1511, 1464, 1294, 1243, 1030, 825 cm–1; HRMS (ESI+) m/z calc’d for C19H26NO4 
[M+H]+: 332.1856, found 332.1871. 
 
 
(E)-3-(3-ethyl-1-(2-methylallyl)-2-oxopiperidin-3-yl)allyl acetate (8k): 
Acetate 8k was prepared from 7k using General Procedure D.  50% isolated yield, 56% 
combined yield with 9k.  Rf = 0.2 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 5.85 (dt, J = 15.9, 1.3 Hz, 1H), 5.60 (dt, J = 15.9, 6.2 Hz, 1H), 4.86 (h, J = 1.3 
Hz, 1H), 4.74 (qt, J = 1.6, 0.7 Hz, 1H), 4.63–4.49 (m, 2H), 4.02–3.95 (m, 1H), 3.94–3.87 
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 (m, 1H), 3.32–3.05 (m, 2H), 2.06 (s, 3H), 1.95–1.74 (m, 5H), 1.73–1.49 (m, 4H), 0.84 (t, 
J = 7.4 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 172.5, 171.0, 140.7, 139.6, 123.6, 112.0, 
65.2, 52.7, 48.6, 47.7, 31.9, 29.3, 21.2, 20.2, 19.4, 8.7; IR (Neat Film, NaCl) 2939, 1740, 
1636, 1489, 1441, 1362, 1230, 1198, 1025, 967, 896 cm–1; HRMS (ESI+) m/z calc’d for 
C16H26NO3 [M+H]+: 280.1907, found 280.1914. 
 
 
(E)-3-(1-cinnamyl-3-ethyl-2-oxopiperidin-3-yl)allyl acetate (8l): 
Acetate 8l was prepared from 7l using General Procedure D.  51% isolated yield, 60% 
combined yield with 9l.  Rf = 0.3 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 7.39–7.28 (m, 4H), 7.26–7.19 (m, 1H), 6.48 (dd, J = 15.9, 1.4 Hz, 1H), 6.14 (dt, 
J = 15.8, 6.5 Hz, 1H), 5.87 (dt, J = 15.9, 1.3 Hz, 1H), 5.60 (dt, J = 15.9, 6.2 Hz, 1H), 
4.65–4.48 (m, 2H), 4.21–4.07 (m, 2H), 3.37–3.20 (m, 2H), 2.06 (s, 3H), 1.91–1.76 (m, 
4H), 1.73–1.61 (m, 2H), 0.85 (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 172.5, 
171.0, 139.5, 136.7, 132.9, 128.7, 127.8, 126.5, 124.7, 123.6, 65.3, 49.6, 48.5, 47.9, 31.8, 
29.1, 21.2, 19.4, 8.6; IR (Neat Film, NaCl) 2939, 1740, 1636, 1490, 1448, 1361, 1232, 
1026, 967, 750, 694 cm–1; HRMS (ESI+) m/z calc’d for C21H28NO3 [M+H]+: 342.2066, 
found 342.2077. 
 
 
(E)-3-(1-benzyl-3-methyl-2-oxoazepan-3-yl)allyl acetate (8m): 
Acetate 8m was prepared from 7m using General Procedure D.  40% isolated yield.  Rf = 
0.3 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.34–7.28 (m, 2H), 
7.26–7.22 (m, 3H), 5.94 (dt, J = 16.0, 1.4 Hz, 1H), 5.54 (dt, J = 16.0, 6.3 Hz, 1H), 4.80 
(d, J = 14.6 Hz, 1H), 4.55 (dt, J = 6.1, 1.3 Hz, 2H), 4.45 (d, J = 14.6 Hz, 1H), 3.51 (ddt, J 
= 15.2, 11.3, 1.1 Hz, 1H), 3.08 (ddd, J = 15.2, 5.7, 2.1 Hz, 1H), 2.03 (s, 3H), 1.84–1.64 
(m, 4H), 1.64–1.52 (m, 2H), 1.35 (s, 3H); 13C NMR (CDCl3, 126 MHz) δ 176.4, 170.9, 
138.9, 138.4, 128.6, 128.3, 127.3, 123.3, 65.1, 53.0, 48.5, 47.6, 36.6, 27.9, 25.3, 21.1; IR 
(Neat Film, NaCl) 2925, 1740, 1636, 1419, 1363, 1236, 1028, 965, 745 cm–1; HRMS 
(ESI+) m/z calc’d for C19H26NO3 [M+H]+: 316.1907, found 316.1921. 
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 (E)-3-(1-benzyl-2-oxoazepan-3-yl)allyl acetate (8n): 
Acetate 8n was prepared from 7n using General Procedure D.  53% isolated yield, 63% 
combined yield with 9n.  Rf = 0.2 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 400 
MHz) δ 7.35–7.22 (m, 5H), 6.18 (ddt, J = 15.6, 8.4, 1.3 Hz, 1H), 5.58 (dtd, J = 15.6, 6.3, 
1.0 Hz, 1H), 4.71 (d, J = 14.6 Hz, 1H), 4.65–4.51 (m, 2H), 4.47 (d, J = 14.6 Hz, 1H), 
3.44 (dd, J = 15.3, 11.1 Hz, 1H), 3.37–3.12 (m, 2H), 2.06 (s, 3H), 1.90 (dd, J = 11.1, 4.6 
Hz, 1H), 1.84–1.71 (m, 1H), 1.71–1.57 (m, 2H), 1.36–1.17 (m, 2H); 13C NMR (CDCl3, 
101 MHz) δ 175.5, 171.0, 137.9, 135.7, 128.7, 128.5, 127.5, 123.8, 65.2, 51.4, 48.0, 47.7, 
31.1, 28.8, 27.6, 21.2; IR (Neat Film, NaCl) 2931, 1740, 1639, 1442, 1364, 1235, 1197, 
1028, 972 cm–1; HRMS (ESI+) m/z calc’d for C18H24NO3 [M+H]+: 302.1751, found 
302.1758. 
 
 
(E)-3-(1-benzyl-3-ethyl-2-oxopyrrolidin-3-yl)allyl acetate (8o): 
Acetate 8o was prepared from 7o using General Procedure D.  66% isolated yield.  Rf = 
0.1 (25% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.35–7.26 (m, 3H), 
7.23–7.17 (m, 2H), 5.87 (dt, J = 15.9, 1.3 Hz, 1H), 5.64 (dt, J = 15.9, 6.2 Hz, 1H), 4.61–
4.52 (m, 2H), 4.50 (d, J = 14.7 Hz, 1H), 4.41 (d, J = 14.7 Hz, 1H), 3.23–3.02 (m, 2H), 
2.11–2.02 (m, 1H), 2.07 (s, 3H), 2.00–1.92 (m, 1H), 1.78–1.63 (m, 1H), 0.88 (t, J = 7.4 
Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 176.2, 170.9, 136.7, 136.6, 128.8, 128.2, 127.7, 
123.9, 65.0, 50.9, 46.9, 43.6, 29.7, 28.2, 21.1, 8.8; IR (Neat Film, NaCl) 2925, 1740, 
1636, 1419, 1363, 1236, 1028, 965, 745 cm–1; HRMS (ESI+) m/z calc’d for C18H24NO3 
[M+H]+: 302.1751, found 302.1759. 
 
 
(E)-3-(1-benzyl-3-methyl-2-oxopyrrolidin-3-yl)allyl acetate (8p): 
Acetate 8p was prepared from 7p using General Procedure D.  48% isolated yield, 54% 
combined yield with 9p.  Rf = 0.1 (40% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 7.35–7.26 (m, 3H), 7.24–7.18 (m, 2H), 5.89 (dt, J = 15.8, 1.3 Hz, 1H), 5.66 (dt, J 
= 15.8, 6.2 Hz, 1H), 4.56 (dt, J = 6.2, 1.5 Hz, 2H), 4.46 (d, J = 3.3 Hz, 2H), 3.26–3.05 
(m, 2H), 2.12 (ddd, J = 12.8, 7.5, 5.5 Hz, 1H), 2.07 (s, 3H), 1.89 (ddd, J = 12.7, 7.7, 6.4 
Hz, 1H), 1.31 (s, 3H); 13C NMR (CDCl3, 126 MHz) δ 176.7, 170.9, 137.5, 136.6, 128.8, 
128.2, 127.7, 123.4, 64.9, 47.1, 46.7, 43.3, 32.5, 32.1, 21.1; IR (Neat Film, NaCl) 2927, 
1738, 1689, 1495, 1428, 1361, 1233, 1028, 972, 740 cm–1; HRMS (ESI+) m/z calc’d for 
C17H22NO3 [M+H]+: 288.1594, found 288.1593. 
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(E)-3-(1,3-dibenzyl-2-oxopyrrolidin-3-yl)allyl acetate (8q): 
Acetate 8q was prepared from 7q using General Procedure D.  50% isolated yield, 58% 
combined yield with 9q.  Rf = 0.2 (40% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 7.29–7.26 (m, 1H), 7.26–7.20 (m, 5H), 7.20–7.14 (m, 2H), 7.11–7.06 (m, 2H), 
5.97 (dt, J = 15.9, 1.4 Hz, 1H), 5.63 (dt, J = 15.8, 6.1 Hz, 1H), 4.63–4.51 (m, 2H), 4.45 
(d, J = 14.7 Hz, 1H), 4.27 (d, J = 14.7 Hz, 1H), 3.15 (d, J = 13.3 Hz, 1H), 2.98 (ddd, J = 
9.6, 8.0, 6.2 Hz, 1H), 2.77 (d, J = 13.3 Hz, 1H), 2.61 (ddd, J = 9.6, 8.3, 4.9 Hz, 1H), 2.07 
(s, 3H), 2.06–1.99 (m, 1H), 1.94 (ddd, J = 13.0, 8.0, 4.9 Hz, 1H); 13C NMR (CDCl3, 126 
MHz) δ 175.4, 170.9, 137.0, 137.0, 136.3, 130.5, 128.7, 128.2, 128.2, 127.6, 126.8, 124.1, 
64.8, 51.8, 47.0, 43.5, 43.0, 28.0, 21.1; IR (Neat Film, NaCl) 2920, 1740, 1685, 1495, 
1437, 1361, 1230, 1028, 973, 743 cm–1; HRMS (ESI+) m/z calc’d for C23H26NO3 
[M+H]+: 364.1907, found 364.1931. 
 
 
(E)-3-(1-benzyl-2-oxopyrrolidin-3-yl)allyl acetate (8r): 
Acetate 8r was prepared from 7r using General Procedure D.  57% isolated yield, 61% 
combined yield with 9r.  Rf = 0.3 (50% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 7.36–7.27 (m, 3H), 7.25–7.19 (m, 2H), 5.92 (ddt, J = 15.5, 6.6, 1.3 Hz, 1H), 5.76 
(dtd, J = 15.6, 6.1, 1.4 Hz, 1H), 4.59 (dq, J = 6.3, 1.2 Hz, 2H), 4.49 (d, J = 14.6 Hz, 1H), 
4.44 (d, J = 14.7 Hz, 1H), 3.28–3.12 (m, 3H), 2.26 (dddd, J = 12.8, 8.8, 6.7, 4.1 Hz, 1H), 
2.08 (s, 3H), 1.91 (dq, J = 12.7, 8.5 Hz, 1H); 13C NMR (CDCl3, 126 MHz) δ 174.2, 
170.9, 136.5, 132.2, 128.9, 128.3, 127.8, 126.7, 64.8, 47.1, 45.0, 44.9, 25.0, 21.1; IR 
(Neat Film, NaCl) 2923, 1735, 1685, 1430, 1363, 1238, 1027, 971 cm–1; HRMS (ESI+) 
m/z calc’d for C16H20NO3 [M+H]+: 274.1438, found 274.1447. 
 
 
(S)-(6-oxo-4-(prop-1-en-2-yl)cyclohex-1-en-1-yl)methyl acetate (18): 
To a flame-dried 25 mL round-bottom flask with a magnetic stir bar were added, in order, 
(S)-carvone (17, 30 mg, 0.2 mmol, 1.00 equiv), palladium(II) acetate (9 mg, 0.04 mmol, 
0.20 equiv), and Oxone (68 mg, 0.22 mmol, 1.10 equiv).  The flask was then capped with 
a rubber septum and evacuated and backfilled twice with nitrogen.  Acetic acid (1.00 mL) 
was added by syringe.  The resulting suspension was stirred under nitrogen for 5 minutes 
at 23 °C and then heated to 95 °C in an oil bath.  Although TLC analysis did not show 
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 full consumption of 17, the reaction was stopped at 16 hours.  The flask was allowed to 
cool to 23 °C and the contents were filtered through a short plug of silica gel, rinsing with 
ethyl acetate.  The filtrate was adsorbed onto silica gel (approx. 2 g), which was then 
flushed with ethyl acetate.  The eluent was concentrated to give the crude product as an 
oil.  The crude residue was purified by silica gel column chromatography (15% ethyl 
acetate in hexanes) to provide recovered (S)-carvone (14 mg, 0.096 mmol, 48% yield, 
52% conversion) and acetate 18 as a colorless oil (8.7 mg, 21% yield, 40% yield based on 
recovered starting material).  Rf = 0.3 (25% ethyl acetate in hexanes); 1H NMR (CDCl3, 
500 MHz) δ 6.75 (ddq, J = 5.6, 2.8, 1.4 Hz, 1H), 5.18 (q, J = 0.9 Hz, 1H), 5.05 (dd, J = 
1.3, 0.7 Hz, 1H), 4.61 (dd, J = 12.8, 1.0 Hz, 1H), 4.59–4.53 (m, 1H), 2.87–2.74 (m, 1H), 
2.64 (ddd, J = 16.0, 3.7, 1.6 Hz, 1H), 2.53 (dddt, J = 18.2, 6.0, 4.5, 1.5 Hz, 1H), 2.40 (dd, 
J = 16.1, 13.2 Hz, 1H), 2.35–2.26 (m, 1H), 2.10 (s, 3H), 1.80 (dt, J = 2.6, 1.4 Hz, 3H).; 
13C NMR (CDCl3, 126 MHz) δ 199.3, 170.8, 145.4, 144.3, 135.8, 113.8, 65.9, 43.2, 38.6, 
31.5, 21.1, 15.9; IR (Neat Film, NaCl) 2923, 1741, 1673, 1433, 1371, 1227, 1109, 1029, 
903 cm–1; HRMS (FAB+) m/z calc’d for C12H17O3 [M+H]+: 209.1178, found 209.1187. 
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 Enal Characterization Data 
 
 
(E)-3-(1-benzyl-3-ethyl-2-oxopiperidin-3-yl)acrylaldehyde (9a): 
Enal 9a was prepared from 7a using General Procedure E.  50% isolated yield, 56% 
combined yield with 8a.  Rf = 0.2 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 9.57 (d, J = 7.6 Hz, 1H), 7.37–7.27 (m, 3H), 7.25–7.18 (m, 2H), 7.06 (d, J = 16.2 
Hz, 1H), 6.13 (dd, J = 16.2, 7.7 Hz, 1H), 4.70 (d, J = 14.5 Hz, 1H), 4.49 (d, J = 14.5 Hz, 
1H), 3.45–3.05 (m, 2H), 2.03–1.89 (m, 3H), 1.85–1.69 (m, 3H), 0.88 (t, J = 7.5 Hz, 3H); 
13C NMR (CDCl3, 126 MHz) δ 194.2, 171.4, 161.9, 137.1, 131.6, 128.8, 128.1, 127.7, 
50.9, 49.8, 47.7, 31.6, 28.5, 19.5, 8.6; IR (Neat Film, NaCl) 2940, 1713, 1689, 1634, 
1606, 1495, 1453, 1356, 1262, 1198, 982, 735 cm–1; HRMS (ESI+) m/z calc’d for 
C17H22NO2 [M+H]+: 272.1645, found 272.1647. 
 
 
(E)-3-(1-benzyl-3-methyl-2-oxopiperidin-3-yl)acrylaldehyde (9b): 
Enal 9b was prepared from 7b using General Procedure E.  67% isolated yield.  Rf = 0.1 
(33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 9.57 (d, J = 7.6 Hz, 1H), 
7.37–7.27 (m, 3H), 7.25–7.17 (m, 2H), 7.08 (d, J = 16.1 Hz, 1H), 6.15 (dd, J = 16.1, 7.6 
Hz, 1H), 4.61 (d, J = 14.5 Hz, 1H), 4.56 (d, J = 14.5 Hz, 1H), 3.33–3.10 (m, 2H), 2.09–
1.94 (m, 1H), 1.94–1.71 (m, 3H), 1.47 (s, 3H); 13C NMR (CDCl3, 126 MHz) δ 194.2, 
171.7, 162.5, 137.1, 130.9, 128.9, 128.2, 127.7, 50.8, 47.8, 45.8, 33.4, 26.3, 19.5; IR 
(Neat Film, NaCl) 2931, 1689, 1638, 1488, 1453, 1351, 1198, 1106, 978, 735, 702 cm–1; 
HRMS (ESI+) m/z calc’d for C16H20NO2 [M+H]+: 258.1489, found 258.1500. 
 
 
(E)-3-(1,3-dibenzyl-2-oxopiperidin-3-yl)acrylaldehyde (9c): 
Enal 9c was prepared from 7c using General Procedure E.  50% isolated yield, 56% 
combined yield with 8c.  Rf = 0.4 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 9.59 (d, J = 7.6 Hz, 1H), 7.32–7.26 (m, 4H), 7.26–7.23 (m, 2H), 7.20–7.10 (m, 
4H), 7.04 (d, J = 16.2 Hz, 1H), 6.10 (dd, J = 16.1, 7.6 Hz, 1H), 4.79 (d, J = 14.5 Hz, 1H), 
4.41 (d, J = 14.5 Hz, 1H), 3.46 (d, J = 13.3 Hz, 1H), 3.22–3.00 (m, 2H), 2.88 (d, J = 13.3 
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 Hz, 1H), 1.99–1.77 (m, 2H), 1.79–1.61 (m, 2H); 13C NMR (CDCl3, 126 MHz) δ 194.0, 
170.4, 161.6, 136.8, 136.2, 132.0, 131.0, 128.8, 128.3, 128.1, 127.6, 127.1, 51.2, 51.1, 
47.8, 44.5, 29.3, 19.5; IR (Neat Film, NaCl) 2924, 1689, 1636, 1494, 1453, 1355, 1194, 
982, 743 cm–1; HRMS (ESI+) m/z calc’d for C22H24NO2 [M+H]+: 334.1802, found 
334.1802. 
 
 
(E)-3-(1-benzyl-2-oxo-3-propylpiperidin-3-yl)acrylaldehyde (9d): 
Enal 9d was prepared from 7d using General Procedure E.  55% isolated yield, 62% 
combined yield with 8d.  Rf = 0.5 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 9.57 (d, J = 7.7 Hz, 1H), 7.36–7.26 (m, 3H), 7.25–7.19 (m, 2H), 7.06 (d, J = 16.2 
Hz, 1H), 6.12 (dd, J = 16.2, 7.6 Hz, 1H), 4.67 (d, J = 14.5 Hz, 1H), 4.51 (d, J = 14.6 Hz, 
1H), 3.40–3.03 (m, 2H), 1.93 (dd, J = 7.3, 4.6 Hz, 2H), 1.91–1.84 (m, 1H), 1.84–1.68 (m, 
3H), 1.38–1.15 (m, 2H), 0.93 (t, J = 7.3 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 194.2, 
171.4, 162.1, 137.1, 131.4, 128.8, 128.2, 127.7, 51.0, 49.7, 47.7, 41.1, 29.2, 19.6, 17.5, 
14.5; IR (Neat Film, NaCl) 2957, 1688, 1634, 1489, 1453, 1352, 1196, 982, 736 cm–1; 
HRMS (ESI+) m/z calc’d for C18H24NO2 [M+H]+: 286.1802, found 286.1808. 
 
 
(E)-3-(1-benzyl-3-(2-methoxyethyl)-2-oxopiperidin-3-yl)acrylaldehyde (9e): 
Enal 9e was prepared from 7e using General Procedure E.  54% isolated yield.  Rf = 0.3 
(50% ethyl acetate in hexanes); 9.57 (d, J = 7.6 Hz, 1H), 7.36–7.27 (m, 3H), 7.25–7.21 
(m, 2H), 7.03 (d, J = 16.1 Hz, 1H), 6.16 (dd, J = 16.2, 7.6 Hz, 1H), 4.71 (d, J = 14.5 Hz, 
1H), 4.48 (d, J = 14.5 Hz, 1H), 3.46 (td, J = 6.4, 1.7 Hz, 2H), 3.28 (s, 3H), 3.26–3.16 (m, 
2H), 2.22 (dt, J = 14.1, 6.6 Hz, 1H), 2.13–2.02 (m, 2H), 1.97 (dddd, J = 13.8, 6.7, 3.3, 1.1 
Hz, 1H), 1.83 (ddtd, J = 13.5, 6.7, 5.0, 3.4 Hz, 1H), 1.79–1.66 (m, 1H); 13C NMR 
(CDCl3, 126 MHz) δ 194.1, 170.9, 161.6, 137.1, 131.6, 128.8, 128.2, 127.7, 69.2, 58.7, 
51.0, 48.7, 47.8, 38.2, 30.2, 19.6; IR (Neat Film, NaCl) 2927, 1685, 1636, 1490, 1452, 
1355, 1196, 1112, 979, 736 cm–1; HRMS (ESI+) m/z calc’d for C18H24NO3 [M+H]+: 
302.1751, found 302.1759. 
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(E)-3-(1-benzyl-2-oxo-3-phenylpiperidin-3-yl)acrylaldehyde (9f): 
Enal 9f was prepared from 7f using General Procedure E.  48% isolated yield, 54% 
combined yield with 8f.  Rf = 0.2 (20% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 9.61 (d, J = 7.7 Hz, 1H), 7.53 (d, J = 16.2 Hz, 1H), 7.42–7.26 (m, 8H), 7.25–7.21 
(m, 2H), 6.17 (dd, J = 16.2, 7.7 Hz, 1H), 4.83 (d, J = 14.3 Hz, 1H), 4.59 (d, J = 14.3 Hz, 
1H), 3.38–3.17 (m, 2H), 2.37 (ddd, J = 13.5, 5.5, 3.3 Hz, 1H), 2.30–2.07 (m, 1H), 1.83–
1.61 (m, 2H); 13C NMR (CDCl3, 126 MHz) δ 194.4, 169.9, 161.3, 140.8, 137.0, 130.5, 
128.9, 128.5, 127.8, 127.6, 127.3, 54.6, 51.1, 47.4, 32.0, 18.7; IR (Neat Film, NaCl) 2937, 
1683, 1634, 1494, 1446, 1352, 1196, 763 cm–1; HRMS (ESI+) m/z calc’d for C21H22NO2 
[M+H]+: 320.1645, found 320.1658. 
 
 
(E)-3-(3-ethyl-1-methyl-2-oxopiperidin-3-yl)acrylaldehyde (9g): 
Enal 9g was prepared from 7g using General Procedure E.  59% isolated yield.  Rf = 0.2 
(33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 9.55 (d, J = 7.6 Hz, 1H), 
7.01 (d, J = 16.2 Hz, 1H), 6.09 (dd, J = 16.2, 7.7 Hz, 1H), 3.35 (ddd, J = 11.9, 8.7, 5.0 
Hz, 1H), 3.25 (ddd, J = 12.1, 5.8, 4.9 Hz, 1H), 2.95 (s, 3H), 1.97–1.72 (m, 6H), 0.84 (t, J 
= 7.5 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 194.2, 171.4, 161.9, 131.6, 50.4, 49.6, 
35.5, 31.4, 28.5, 19.5, 8.5; IR (Neat Film, NaCl) 2939, 1688, 1635, 1506, 1456, 1257, 
1204, 1104 cm–1; HRMS (ESI+) m/z calc’d for C11H18NO2 [M+H]+: 196.1332, found 
196.1328. 
 
 
(E)-3-(3-ethyl-2-oxopiperidin-3-yl)acrylaldehyde (9h): 
Enal 9h was prepared from 7h using General Procedure E.  44% isolated yield, 53% 
combined yield with 8h.  Rf = 0.1 (20% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 9.55 (d, J = 7.6 Hz, 1H), 6.98 (d, J = 16.1 Hz, 1H), 6.14 (dd, J = 16.2, 7.6 Hz, 
1H), 5.85 (s, 1H), 3.46–3.26 (m, 2H), 2.01–1.90 (m, 3H), 1.90–1.84 (m, 1H), 1.84–1.73 
(m, 2H), 0.90 (t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 194.1, 173.4, 161.1, 
131.8, 49.4, 42.8, 31.1, 28.3, 19.3, 8.4; IR (Neat Film, NaCl) 3287, 2941, 1687, 1662, 
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 1489, 1464, 1354, 1107, 983 cm–1; HRMS (ESI+) m/z calc’d for C10H16NO2 [M+H]+: 
182.1176, found 182.1177. 
 
 
(E)-3-(3-ethyl-1-(4-methoxyphenyl)-2-oxopiperidin-3-yl)acrylaldehyde (9j): 
Enal 9j was prepared from 7j using General Procedure E.  53% isolated yield, 58% 
combined yield with 8j.  Rf = 0.2 (33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 9.58 (d, J = 7.6 Hz, 1H), 7.14–7.10 (m, 2H), 7.07 (d, J = 16.2 Hz, 1H), 6.94–6.87 
(m, 2H), 6.19 (dd, J = 16.2, 7.6 Hz, 1H), 3.81 (s, 3H), 3.66 (ddd, J = 12.1, 8.7, 5.0 Hz, 
1H), 3.62–3.52 (m, 1H), 2.16–1.89 (m, 5H), 1.83 (dq, J = 13.7, 7.5 Hz, 1H), 0.94 (t, J = 
7.4 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 194.2, 171.7, 161.9, 158.4, 136.2, 131.6, 
127.5, 114.6, 55.6, 52.5, 50.1, 31.7, 28.7, 20.1, 8.6; IR (Neat Film, NaCl) 2938, 1685, 
1647, 1510, 1295, 1243, 1130, 1032, 982, 827 cm–1; HRMS (ESI+) m/z calc’d for 
C17H22NO3 [M+H]+: 288.1594, found 288.1604. 
 
 
(E)-3-(1,3-dibenzyl-2-oxopyrrolidin-3-yl)acrylaldehyde (9q): 
Enal 9q was prepared from 7q using General Procedure E.  30% isolated yield.  Rf = 0.4 
(33% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 9.58 (d, J = 7.6 Hz, 1H), 
7.30–7.26 (m, 3H), 7.26–7.22 (m, 3H), 7.20–7.14 (m, 2H), 7.12–7.04 (m, 3H), 6.12 (dd, J 
= 16.0, 7.6 Hz, 1H), 4.45 (d, J = 14.7 Hz, 1H), 4.26 (d, J = 14.6 Hz, 1H), 3.24 (d, J = 13.4 
Hz, 1H), 3.07–2.88 (m, 1H), 2.83 (d, J = 13.4 Hz, 1H), 2.69–2.52 (m, 1H), 2.18 (ddd, J = 
13.3, 8.2, 5.2 Hz, 1H), 2.11–1.98 (m, 1H); 13C NMR (CDCl3, 126 MHz) δ 193.8, 173.8, 
158.9, 135.9, 131.7, 130.4, 128.9, 128.6, 128.3, 127.9, 127.4, 53.1, 47.3, 43.5, 42.8, 27.4; 
IR (Neat Film, NaCl) 2921, 1738, 1683, 1495, 1454, 1246, 981, 745, 702 cm–1; HRMS 
(ESI+) m/z calc’d for C21H22NO2 [M+H]+: 320.1645, found 320.1640. 
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 Attempted Enal Formation on 18 
 
 
1-benzyl-3-methyl-3-(2-oxopropyl)azetidin-2-one (16): 
Ketone 16 was prepared from 17 using General Procedure E (0.2 mmol 7u, 1.5 hour 
reaction time).  45% isolated yield.  Rf = 0.1 (25% ethyl acetate in hexanes); 1H NMR 
(CDCl3, 500 MHz) δ 7.39–7.27 (m, 3H), 7.25–7.21 (m, 2H), 4.40 (d, J = 14.9 Hz, 1H), 
4.33 (d, J = 14.9 Hz, 1H), 3.18 (d, J = 5.9 Hz, 1H), 3.07–3.01 (m, 1H), 2.83 (d, J = 17.6 
Hz, 1H), 2.72 (d, J = 17.6 Hz, 1H), 2.16 (s, 3H), 1.35 (s, 3H).; 13C NMR (CDCl3, 126 
MHz) δ 206.3, 172.5, 135.7, 129.0, 128.3, 127.9, 52.3, 51.5, 46.8, 45.9, 31.0, 19.6; IR 
(Neat Film, NaCl) 2961, 2894, 1746, 1716, 1455, 1410, 1361, 1177, 739, 700 cm–1; 
HRMS (ESI+) m/z calc’d for C14H18NO2 [M+H]+: 232.1332, found 232.1333. 
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 Allylic Acetate Derivitization Procedures and Characterization Data 
 
 
3-(1-benzyl-3-ethyl-2-oxopiperidin-3-yl)-2,3-dihydroxypropyl acetate (10): 
To a 1 dram screw-top vial with a magnetic stir bar were added, in order, acetate 8a (18 
mg, 0.057 mmol, 1.00 equiv), acetone (reagent grade, 540 µL), deionized water (180 µL), 
potassium osmate(VI) dehydrate (2 mg, 0.006 mmol, 0.10 equiv), and 4-
methylmorpholine N-oxide (13 mg, 0.144 mmol, 2.00 equiv).  The vial was sealed with a 
Teflon-lined cap and the purple solution was stirred at 23 °C for 3 hours.  Upon 
completion (as determined by TLC analysis), the reaction mixture was adsorbed onto 
Celite and purified by silica gel column chromatography (50% ethyl acetate in hexanes) 
to provide the major diastereomer 10 as colorless crystals (16.5 mg, 83% yield).  Rf = 0.3 
(50% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.36–7.30 (m, 2H), 7.29–
7.26 (m, 2H), 7.26–7.23 (m, 1H), 5.96 (d, J = 8.5 Hz, 1H), 4.60 (d, J = 14.7 Hz, 1H), 4.56 
(d, J = 14.8 Hz, 1H), 4.28 (dd, J = 11.5, 7.5 Hz, 1H), 4.22 (dd, J = 11.5, 4.8 Hz, 1H), 3.96 
(dddd, J = 9.6, 7.5, 4.8, 1.5 Hz, 1H), 3.52 (dd, J = 8.5, 1.4 Hz, 1H), 3.31–3.07 (m, 2H), 
2.27 (d, J = 9.7 Hz, 1H), 2.10 (s, 3H), 2.03–1.93 (m, 1H), 1.93–1.85 (m, 1H), 1.85–1.77 
(m, 2H), 1.77–1.63 (m, 2H), 0.92 (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 
176.9, 171.3, 136.7, 128.8, 128.1, 127.6, 75.8, 69.8, 67.5, 50.5, 47.1, 45.4, 30.2, 27.3, 
21.2, 20.0, 8.1; IR (Neat Film, NaCl) 3382, 2936, 2878, 1736, 1606, 1495, 1453, 1362, 
1248, 1206, 1039, 737 cm–1; HRMS (ESI+) m/z calc’d for C19H28NO5 [M+H]+: 350.1962, 
found 350.1977. 
 
Colorless, translucent X-ray quality crystals of diol 10 were obtained by slow diffusion of 
2% benzene in pentane into a solution of 10 in ether at –20 °C, mp: 86–88 °C. 
 
 
(3-(1-benzyl-3-ethyl-2-oxopiperidin-3-yl)oxiran-2-yl)methyl acetate (11): 
To a 1 dram screw-top vial with a magnetic stir bar were added, in order, acetate 8a (10 
mg, 0.032 mmol, 1.00 equiv), 3-chloroperbezoic acid (54 mg, 0.32 mmol, 10.00 equiv), 
and dichloromethane (320 µL).  The vial was sealed with a Teflon-lined cap and the pale 
yellow solution was stirred at 23 °C for 12 hours.  Upon completion (as determined by 
TLC analysis), the reaction mixture was diluted with dichloromethane (3 mL) and 
quenched with saturated aqueous sodium thiosulfate (3 mL).  The organic layer was 
separated and washed with saturated aqueous sodium bicarbonate solution (3 x 3 mL), 
dried over sodium sulfate, filtered, and concentrated in vacuo.  NMR analysis of the 
crude reaction mixture showed a single diasteromer.  The crude was residue purified by 
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 silica gel column chromatography (25% ethyl acetate and 1% triethylamine in hexanes) 
to provide epoxide 11 as a colorless oil (9.9 mg, 93% yield, single diastereomer).  Rf = 
0.5 (50% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.36–7.27 (m, 3H), 
7.24 (ddt, J = 7.6, 1.4, 0.7 Hz, 2H), 4.67 (d, J = 14.6 Hz, 1H), 4.56 (d, J = 14.6 Hz, 1H), 
4.42 (dd, J = 12.2, 3.1 Hz, 1H), 3.97 (dd, J = 12.3, 6.3 Hz, 1H), 3.46 (d, J = 2.3 Hz, 1H), 
3.20–3.15 (m, 2H), 3.13 (ddd, J = 6.3, 3.1, 2.4 Hz, 1H), 2.11 (s, 3H), 1.90 (dq, J = 13.8, 
7.5 Hz, 1H), 1.85–1.72 (m, 1H), 1.68 (dt, J = 13.8, 7.5 Hz, 1H), 1.61–1.51 (m, 2H), 0.91 
(t, J = 7.5 Hz, 4H); 13C NMR (CDCl3, 126 MHz) δ 172.6, 170.9, 137.3, 128.8, 128.0, 
127.5, 64.8, 60.9, 52.2, 50.9, 47.6, 45.4, 28.9, 24.2, 20.9, 19.8, 8.7; IR (Neat Film, NaCl) 
2940, 1744, 1632, 1494, 1453, 1364, 1232, 1037, 907, 735 cm–1; HRMS (ESI+) m/z 
calc’d for C19H26NO4 [M+H]+: 332.1856, found 332.1853. 
 
 
dimethyl (E)-2-(3-(1-benzyl-3-ethyl-2-oxopiperidin-3-yl)allyl)malonate (12): 
The conditions for the transformation were adapted from a known procedure.17  In a 
nitrogen-filled glovebox, an oven-dried 1 dram screw-top vial with a magnetic stir bar 
was charged with dichloro(p-cymene)ruthenium(II) dimer (12 mg, 0.019 mmol, 0.50 
equiv), triphenylphosphine (10 mg, 0.038 mmol, 1.00 equiv), and toluene (150 µL).  To 
this solution was added a solution of acetate 8a (12 mg, 0.038 mmol, 1.00 equiv) in 
toluene (100 µL).  Dimethyl malonate (7 µL, 0.057 mmol, 1.50 equiv) was then added, 
followed by a solution of lithium hexamethyldisilazide (9 mg, 0.052 mmol, 1.40 equiv) in 
THF (100 µL).  The vial was sealed with a Teflon-lined cap and heated at 60 °C for 90 
hours.  Upon completion (as determined by LCMS analysis) the reaction was removed 
from the glovebox, adsorbed onto Celite, and purified by silica gel column 
chromatography (20% ethyl acetate in hexanes) to provide malonate 12 as a colorless oil 
(12.1 mg, 82% yield.  Rf = 0.2 (25% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 
MHz) δ 7.35–7.28 (m, 3H), 7.25–7.20 (m, 2H), 5.65 (dt, J = 15.8, 1.3 Hz, 1H), 5.44 (dt, J 
= 15.8, 7.0 Hz, 1H), 4.62 (d, J = 14.6 Hz, 1H), 4.53 (d, J = 14.5 Hz, 1H), 3.71 (s, 3H), 
3.71 (s, 3H), 3.45 (t, J = 7.6 Hz, 1H), 3.32–3.04 (m, 2H), 2.66 (ddd, J = 7.5, 7.0, 1.3 Hz, 
2H), 1.84 (dq, J = 13.5, 7.4 Hz, 1H), 1.80–1.67 (m, 4H), 1.67–1.58 (m, 1H), 0.83 (t, J = 
7.4 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 173.0, 169.5, 169.5, 138.1, 137.7, 128.7, 
128.1, 127.4, 125.0, 52.6, 52.6, 52.0, 50.6, 48.6, 47.8, 32.3, 32.1, 29.3, 19.3, 8.6; IR (Neat 
Film, NaCl) 2952, 1734, 1635, 1437, 1350, 1261, 1195, 1153, 740 cm–1; HRMS (ESI+) 
m/z calc’d for C22H30NO5 [M+H]+: 388.2118, found 388.2110. 
 
 
3-(1-benzyl-3-ethyl-2-oxopiperidin-3-yl)propyl acetate (S11): 
BnN
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O
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(99% yield)
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 To a round-bottom flask with a magnetic stir bar were added acetate 8a (40 mg, 0.13 
mmol, 1.00 equiv) and ethyl acetate (750 µL).  Palladium on carbon (10 wt. %, 2 mg) 
was added, and the suspension was stirred vigorously while the air atmosphere was 
replaced with hydrogen by three evacuation/back-fill cycles.  The reaction mixture was 
then stirred at 23 °C under an atmosphere of hydrogen (supplied by a balloon) for 5 
hours.  As TLC analysis showed remaining starting material, an additional 5 mg of 
palladium on carbon (10 wt. %) was added.  After letting the reaction mixture stir for an 
additional 19 hours, TLC analysis showed full conversion.  The mixture was filtered 
through Celite, rinsing with ethyl acetate.  The filtrate was concentrated and the crude 
residue was purified by silica gel column chromatography (25% ethyl acetate in hexanes) 
to provide aliphatic acetate S11 as a colorless oil (34.0 mg, 99% yield).  Rf = 0.7 (50% 
ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.37–7.27 (m, 2H), 7.25–7.19 
(m, 3H), 4.66 (d, J = 14.5 Hz, 1H), 4.50 (d, J = 14.5 Hz, 1H), 4.22–3.85 (m, 2H), 3.29–
3.13 (m, 2H), 2.05 (s, 3H), 1.94–1.50 (m, 10H), 0.89 (t, J = 7.5 Hz, 3H); 13C NMR 
(CDCl3, 126 MHz) δ 174.6, 171.3, 137.8, 128.7, 128.2, 127.4, 65.1, 50.7, 47.8, 44.9, 
34.9, 31.6, 29.4, 24.0, 21.2, 20.0, 8.9; IR (Neat Film, NaCl) 2936, 1737, 1631, 1453, 
1362, 1241, 1038, 738, 701 cm–1; HRMS (ESI+) m/z calc’d for C19H28NO3 [M+H]+: 
318.2064, found 318.2051. 
 
 
(E)-1-benzyl-3-ethyl-3-(3-hydroxyprop-1-en-1-yl)piperidin-2-one (S12): 
To a 1 dram screw-top vial with a magnetic stir bar were added, in order, acetate 8a (102 
mg, 0.32 mmol, 1.00 equiv), freshly powdered potassium hydroxide (27 mg, 0.49 mmol, 
1.50 equiv), methanol (1.3 mL), and water (300 µL).  The vial was sealed with a Teflon-
lined cap and the solution was stirred at 23 °C for 4 minutes.  Upon completion (as 
determined by TLC analysis), the reaction mixture was adsorbed onto Celite and purified 
by silica gel column chromatography (50% ethyl acetate in hexanes) to provide allylic 
alcohol S12 as a colorless oil (88.0 mg, >99% yield).  Rf = 0.2 (50% ethyl acetate in 
hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.35–7.26 (m, 3H), 7.25–7.21 (m, 2H), 5.83 (dt, 
J = 15.9, 1.4 Hz, 1H), 5.75–5.65 (m, 1H), 4.68 (d, J = 14.5 Hz, 1H), 4.50 (d, J = 14.6 Hz, 
1H), 4.26–4.05 (m, 2H), 3.35–3.06 (m, 2H), 1.97–1.86 (m, 1H), 1.86–1.64 (m, 6H), 0.86 
(td, J = 7.4, 1.2 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 173.1, 137.6, 136.6, 128.8, 
128.7, 128.2, 127.4, 63.9, 50.7, 48.4, 47.9, 32.0, 29.3, 19.4, 8.7; IR (Neat Film, NaCl) 
3402, 2936, 2863, 1617, 1494, 1452, 1353, 1196, 981, 734, 701 cm–1; HRMS (ESI+) m/z 
calc’d for C17H24NO2 [M+H]+: 274.1802, found 274.1803. 
 
 
(E)-3-(1-benzyl-3-ethylpiperidin-3-yl)prop-2-en-1-ol (S13): 
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 To an oven-dried 1 dram screw-top vial with a magnetic stir bar were added, in order, 
acetate 8a (30 mg, 0.095 mmol, 1.00 equiv), lithium aluminum hydride (72 mg, 1.90 
mmol, 20.00 equiv), and THF (500 µL).  The vial was sealed with a Teflon-lined cap and 
the suspension was stirred at 70 °C for 10 hours.  Upon completion (as determined by 
TLC analysis), the reaction mixture cooled to 0 °C using an ice water bath.  1.5 mL water 
was added slowly dropwise, followed by 1.5 mL NaOH (15 wt. %), followed by 4.5 mL 
water.  The suspension was stirred until the color turned white (45 minutes), after which 
it was filtered through Celite, rinsing with ether.  The filtrate was concentrated and the 
crude residue was purified by silica gel column chromatography (50% ethyl acetate and 
1% triethylamine in hexanes with) to provide amine S13 as a colorless oil (23.9 mg, 97 % 
yield).  Rf = 0.3 (50% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.33–
7.27 (m, 4H), 7.26–7.21 (m, 1H), 5.58 (dt, J = 16.0, 5.7 Hz, 1H), 5.50 (dt, J = 15.9, 1.0 
Hz, 1H), 4.12 (d, J = 5.6 Hz, 2H), 3.44 (s, 2H), 2.51–1.95 (m, 4H), 1.75 (s, 1H), 1.59 (m, 
1H), 1.50 (d, J = 15.5 Hz, 3H), 1.37 (dt, J = 13.8, 7.2 Hz, 2H), 0.70 (t, J = 7.5 Hz, 3H); 
13C NMR (CDCl3, 126 MHz) δ 139.7, 139.0, 129.1, 128.2, 127.6, 127.0, 64.5, 63.7, 62.8, 
54.8, 39.3, 33.4, 22.3, 7.9; IR (Neat Film, NaCl) 3326, 2934, 1453, 1349, 1091, 974, 739, 
698 cm–1; HRMS (ESI+) m/z calc’d for C17H26NO [M+H]+: 260.2009, found 260.2018. 
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 Enal Derivitization Procedures and Characterization Data 
 
 
(E)-1-benzyl-3-(buta-1,3-dien-1-yl)-3-ethylpiperidin-2-one (13): 
The conditions for the transformation were adapted from a known procedure.18  To a 1 
dram screw-top vial with a magnetic stir bar were added, in order, vanadyl 
acetylacetonate (1 mg, 0.001 mmol, 0.04 equiv) and hydrogen peroxide (35 wt. % in 
water, 50 µL).  A solution of enal 9a (10 mg, 0.04 mmol, 1.00 equiv) in methanol (200 
µL) was then added.  The vial was sealed with a Teflon-lined cap and the solution was 
stirred at 23 °C for 17 hours.  Upon completion (as determined by TLC analysis), the 
reaction mixture was diluted with dichloromethane (3 mL), adsorbed onto Celite and 
purified by silica gel column chromatography (25% ethyl acetate in hexanes) to provide 
enoate 13 as a colorless oil (11.2 mg, 93% yield).  Rf = 0.4 (10% ethyl acetate in 
hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.37–7.26 (m, 3H), 7.25–7.18 (m, 2H), 7.04 (d, 
J = 16.1 Hz, 1H), 5.90 (d, J = 16.1 Hz, 1H), 4.68 (d, J = 14.5 Hz, 1H), 4.51 (d, J = 14.5 
Hz, 1H), 3.74 (s, 3H), 3.32–3.09 (m, 2H), 1.95 (dq, J = 13.5, 7.4 Hz, 1H), 1.91–1.82 (m, 
2H), 1.82–1.67 (m, 3H), 0.88 (t, J = 7.4 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 171.4, 
167.2, 152.6, 137.4, 128.8, 128.2, 127.5, 120.8, 51.7, 50.9, 49.3, 47.8, 31.6, 29.3, 19.5, 
8.7; IR (Neat Film, NaCl) 2946, 1723, 1631, 1434, 1341, 1273, 1197, 1020, 701 cm–1; 
HRMS (ESI+) m/z calc’d for C18H24NO3 [M+H]+: 302.1751, found 302.1754. 
 
 
3-(1-benzyl-3-ethyl-2-oxopiperidin-3-yl)propanal (14): 
To a round-bottom flask with a magnetic stir bar were added enal 9a (30 mg, 0.11 mmol, 
1.00 equiv) and ethyl acetate (320 µL).  Palladium on carbon (10 wt. %, 2 mg) was 
added, and the suspension was stirred vigorously while the air atmosphere was replaced 
with hydrogen by three evacuation/back-fill cycles.  The reaction mixture was then 
stirred at 23 °C under one atmosphere of hydrogen (supplied by a balloon) for 1.25 hours.  
After completion (as determined by TLC analysis), the mixture was filtered through 
Celite, rinsing with ethyl acetate.  The filtrate was concentrated and the crude residue was 
purified by silica gel column chromatography (25% ethyl acetate in hexanes) to provide 
aliphatic aldehyde 14 as a colorless oil (29.3 mg, 97% yield).  Rf = 0.5 (50% ethyl acetate 
in hexanes); 1H NMR (CDCl3, 500 MHz) δ 9.77 (t, J = 1.5 Hz, 1H), 7.37–7.27 (m, 3H), 
7.25–7.18 (m, 2H), 4.65 (d, J = 14.5 Hz, 1H), 4.48 (d, J = 14.5 Hz, 1H), 3.36–3.06 (m, 
2H), 2.59 (dddd, J = 17.4, 10.1, 5.7, 1.6 Hz, 1H), 2.49 (dddd, J = 17.3, 10.1, 5.6, 1.5 Hz, 
1H), 1.98 (ddd, J = 14.0, 10.1, 5.6 Hz, 1H), 1.93–1.85 (m, 1H), 1.85–1.71 (m, 3H), 1.67–
1.50 (m, 3H), 0.89 (t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 202.6, 174.1, 
137.7, 128.7, 128.1, 127.5, 50.7, 47.8, 44.4, 39.8, 31.1, 30.3, 29.9, 19.7, 8.6; IR (Neat 
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 Film, NaCl) 2937, 1722, 1628, 1494, 1452, 1351, 1194, 736, 701 cm–1; HRMS (ESI+) 
m/z calc’d for C17H24NO2 [M+H]+: 274.1802, found 274.1805. 
 
  
(E)-4-(1-benzyl-3-ethyl-2-oxopiperidin-3-yl)-1-(tert-butylamino)-1-oxobut-3-en-2-yl 
4-methoxybenzoate (15): 
The conditions for the transformation were adapted from a known procedure.19  To a 0.5 
dram screw-top vial with a magnetic stir bar were added, in order, enal 9a (10 mg, 0.037 
mmol, 1.00 equiv), tert-butyl isocyanide (42 µL, 0.37 mmol, 10.0 equiv), 4-
methoxybenzoic acid (56 mg, 0.37 mmol, 10.0 equiv), and dichloromethane (50 µL).  
The vial was sealed with a Teflon-lined cap and the white suspension was stirred at 23 °C 
for 21 hours, and then at 40 °C for 12 additional hours.  Upon completion (as determined 
by LCMS analysis), the reaction mixture was diluted with dichloromethane (2 mL) and 
washed with saturated aqueous sodium bicarbonate solution (1 x 2 mL).  The organic 
layer was dried over sodium sulfate, filtered, and concentrated in vacuo.  The crude 
residue was purified by silica gel column chromatography (25% ethyl acetate in hexanes) 
to provide the products as an inseparable 1:1 mixture of diastereomers (12.1 mg, 64% 
yield).  Rf = 0.3 (25% ethyl acetate in hexanes); 1H NMR (CDCl3, 500 MHz) δ 8.04 (dd, 
J = 2.1, 1.5 Hz, 1H), 8.03 (dd, J = 2.1, 1.5 Hz, 1H), 7.35–7.27 (m, 1H), 7.25–7.16 (m, 
3H), 6.96 (d, J = 2.5 Hz, 1H), 6.94 (t, J = 2.4 Hz, 1H), 6.07 (ddd, J = 15.9, 9.9, 1.2 Hz, 
1H), 5.87 (d, J = 8.6 Hz, 1H), 5.78 (ddd, J = 15.9, 9.8, 6.7 Hz, 1H), 5.69 (ddd, J = 6.9, 
3.3, 1.2 Hz, 1H), 4.64 (dd, J = 26.6, 14.6 Hz, 1H), 4.52 (dd, J = 14.6, 6.6 Hz, 1H), 3.88 
(d, J = 1.1 Hz, 3H), 3.33–3.02 (m, 2H), 1.96–1.80 (m, 3H), 1.80–1.61 (m, 1H), 1.35 (d, J 
= 1.7 Hz, 9H), 0.86 (td, J = 7.4, 5.8 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 172.7, 
172.7, 167.8, 167.7, 164.8, 163.9, 163.9, 140.0, 139.8, 137.5, 132.4, 132.0, 132.0, 128.7, 
128.7, 128.0, 128.0, 127.4, 127.4, 124.2, 124.0, 121.9, 121.9, 114.0, 114.0, 113.8, 75.0, 
74.8, 55.7, 51.5, 51.5, 50.7, 50.6, 48.7, 48.6, 47.8, 47.8, 36.8, 32.0, 31.7, 29.1, 29.1, 28.8, 
24.8, 19.4, 19.3, 8.6, 8.6; IR (Neat Film, NaCl) 3320, 2965, 1691, 1606, 1453, 1256, 
1168, 1102, 1028 cm–1; HRMS (ESI+) m/z calc’d for C30H39N2O5 [M+H]+: 507.2853, 
found 507.2857. 
 
 
(E)-1-benzyl-3-(buta-1,3-dien-1-yl)-3-ethylpiperidin-2-one (S14): 
To a flame-dried round-bottom flask with a magnetic stir bar were added methyl 
triphenylphosphonium bromide (64 mg, 0.18 mmol, 1.25 equiv) and THF (0.9 mL).  The 
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 white suspension was cooled to 0 °C using an ice water bath and n-butyllithium (2.5 M in 
hexanes, 72 µL, 1.25 equiv) was added dropwise by syringe.  The mixture was stirred for 
15 minutes at 0 °C and a solution of enal 9a (40 mg, 0.15 mmol, 1.00 equiv) in THF (180 
µL) was added dropwise by syringe.  The mixture was stirred for 1 hour at 0 °C and 20 
hours at 23 °C.  As the reaction was not progressing, additional ylide (1.25 equiv, 
generated as described above) was added by syringe at 0 °C.  The reaction was allowed to 
stir at 23 °C for 5 hours, at which point additional ylide (2.50 equiv, generated as 
described above) was added at 0 °C.  After stirring for 3 hours at 23 °C, TLC analysis 
showed complete consumption of the starting material.  The reaction was quenched by 
addition of saturated aqueous ammonium chloride solution (5 mL).  The mixture was 
extracted with ether (3 x 5 mL), and the combined organic layers were washed with brine 
(1 x 5 mL), dried over magnesium sulfate, filtered, and concentrated in vacuo.  The crude 
residue was purified by silica gel column chromatography (20% ethyl aceate in hexanes) 
to provide diene S14 as a colorless oil (32.1 mg, 79% yield).  Rf = 0.5 (25% ethyl acetate 
in hexanes); 1H NMR (CDCl3, 500 MHz) δ 7.34–7.26 (m, 2H), 7.26–7.21 (m, 3H), 6.35 
(dtd, J = 16.9, 10.2, 0.7 Hz, 1H), 6.10 (ddd, J = 15.7, 10.2, 0.7 Hz, 1H), 5.81 (dd, J = 
15.7, 0.8 Hz, 1H), 5.14 (ddt, J = 17.0, 1.6, 0.7 Hz, 1H), 5.03 (ddt, J = 10.1, 1.6, 0.7 Hz, 
1H), 4.62 (d, J = 14.6 Hz, 1H), 4.57 (d, J = 14.6 Hz, 1H), 3.35–2.98 (m, 2H), 1.90 (dq, J 
= 13.6, 7.5 Hz, 1H), 1.86–1.78 (m, 3H), 1.78–1.64 (m, 2H), 0.86 (t, J = 7.4 Hz, 3H); 13C 
NMR (CDCl3, 126 MHz) δ 172.9, 139.0, 137.7, 137.3, 130.3 128.7, 128.2, 127.4, 116.4, 
50.7, 48.8, 47.9, 32.2, 29.4, 19.5, 8.8; IR (Neat Film, NaCl) 2966, 1635, 1600, 1488, 
1452, 1352, 1196, 1007, 733, 701 cm–1; HRMS (ESI+) m/z calc’d for C18H24NO [M+H]+: 
270.1853, found 270.1851. 
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 Mechanistic Investigation Experiments 
 
 
Oxidation of allylic alcohol S12 to enal 9a: 
To a 0.5 dram vial with a magnetic stir bar were added, in order, allylic alcohol S12 (11 
mg, 0.04 mmol, 1.00 equiv), palladium(II) acetate (1 mg, 0.03 mmol, 0.075 equiv), and 
Oxone (31 mg, 0.10 mmol, 2.5 equiv).  Acetonitrile (400 µL), acetic acid (37 µL, 3.2 
mmol, 16.00 equiv), and water (6 µL, 1.6 mmol, 8.00 equiv) were added by syringe.  The 
resulting suspension was stirred for 5 minutes at 23 °C and then heated to 50 °C in an oil 
bath.  Upon completion (as determined by TLC analysis), the flask was allowed to cool to 
23 °C.  The reaction mixture was filtered through a plug of silica gel, rinsing with ethyl 
acetate, and concentrated to give the crude product, which was identical to 9a by 1H 
NMR, TLC, and LCMS analysis. 
 
 
 
Oxidation of aliphatic aldehyde 14 to enal 9a: 
To a 0.5 dram vial with a magnetic stir bar were added, in order, aliphatic aldehyde 14 (3 
mg, 0.011 mmol, 1.00 equiv), palladium(II) acetate (<1 mg, 0.015 mmol, 0.075 equiv), 
and Oxone (8 mg, 0.028 mmol, 2.5 equiv).  Acetonitrile (100 µL), acetic acid (10 µL, 3.2 
mmol, 16.00 equiv), and water (2 µL, 1.6 mmol, 8.00 equiv) were added by syringe.  The 
resulting suspension was stirred for 5 minutes at 23 °C and then heated to 50 °C in an oil 
bath.  Upon completion (as determined by TLC analysis), the flask was allowed to cool to 
23 °C.  The reaction mixture was filtered through a plug of silica gel, rinsing with ethyl 
acetate, and concentrated to give the crude product, which was identical to 9a by 1H 
NMR, TLC, and LCMS analysis. 
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 13C NMR (126 MHz, CDCl3) of compound 7a. 
 
 Infrared spectrum (Thin Film, NaCl) of compound 7a. 
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 13C NMR (126 MHz, CDCl3) of compound 7b. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7b. 
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 13C NMR (126 MHz, CDCl3) of compound 7c. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7c. 
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 13C NMR (126 MHz, CDCl3) of compound 7d. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7d. 
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 13C NMR (126 MHz, CDCl3) of compound 7e. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7e. 
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 13C NMR (126 MHz, CDCl3) of compound 7f. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7f. 
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 13C NMR (126 MHz, CDCl3) of compound 7g. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7g. 
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 13C NMR (126 MHz, CDCl3) of compound 7j. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7j. 
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 13C NMR (126 MHz, CDCl3) of compound 7k. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7k. 
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 13C NMR (126 MHz, CDCl3) of compound 7l. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7l. 
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 13C NMR (126 MHz, CDCl3) of compound 7m. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7m. 
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 13C NMR (126 MHz, CDCl3) of compound 7n. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7n. 
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 13C NMR (126 MHz, CDCl3) of compound 7o. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7o. 
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 13C NMR (126 MHz, CDCl3) of compound 7p. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7p. 
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 13C NMR (126 MHz, CDCl3) of compound 7q. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7q. 
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 13C NMR (126 MHz, CDCl3) of compound 7s. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7s. 
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 13C NMR (126 MHz, CDCl3) of compound 7t. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7t. 
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 13C NMR (126 MHz, CDCl3) of compound S8. 
 
Infrared spectrum (Thin Film, NaCl) of compound S8. 
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 13C NMR (126 MHz, CDCl3) of compound S9. 
 
Infrared spectrum (Thin Film, NaCl) of compound S9. 
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 13C NMR (126 MHz, CDCl3) of compound S10. 
 
Infrared spectrum (Thin Film, NaCl) of compound S10. 
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 13C NMR (126 MHz, CDCl3) of compound 7u. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7u. 
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 13C NMR (126 MHz, CDCl3) of compound 5. 
 
Infrared spectrum (Thin Film, NaCl) of compound 5. 
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 13C NMR (126 MHz, CDCl3) of compound 8a. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8a. 
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 13C NMR (126 MHz, CDCl3) of compound 8b. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8b. 
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 13C NMR (126 MHz, CDCl3) of compound 8c. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8c. 
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 13C NMR (126 MHz, CDCl3) of compound 8d. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8d. 
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 13C NMR (126 MHz, CDCl3) of compound 8e. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8e. 
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 13C NMR (126 MHz, CDCl3) of compound 8f. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8f. 
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 13C NMR (126 MHz, CDCl3) of compound 8g. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8g. 
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 13C NMR (126 MHz, CDCl3) of compound 8h. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8h. 
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 13C NMR (126 MHz, CDCl3) of compound 8i. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8i. 
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 13C NMR (126 MHz, CDCl3) of compound 8j. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8j. 
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 13C NMR (126 MHz, CDCl3) of compound 8k. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8k. 
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 13C NMR (126 MHz, CDCl3) of compound 8l. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8l. 
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 13C NMR (126 MHz, CDCl3) of compound 8m. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8m. 
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 13C NMR (101 MHz, CDCl3) of compound 8n. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8n. 
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 13C NMR (126 MHz, CDCl3) of compound 8o. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8o. 
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 13C NMR (126 MHz, CDCl3) of compound 8p. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8p. 
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 13C NMR (126 MHz, CDCl3) of compound 8q. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8q. 
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 13C NMR (126 MHz, CDCl3) of compound 8r. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8r. 
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 13C NMR (126 MHz, CDCl3) of compound 18. 
 
Infrared spectrum (Thin Film, NaCl) of compound 18. 
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 13C NMR (126 MHz, CDCl3) of compound 9a. 
 
Infrared spectrum (Thin Film, NaCl) of compound 9a. 
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 13C NMR (126 MHz, CDCl3) of compound 9b. 
 
Infrared spectrum (Thin Film, NaCl) of compound 9b. 
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 13C NMR (126 MHz, CDCl3) of compound 9c. 
 
Infrared spectrum (Thin Film, NaCl) of compound 9c. 
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 13C NMR (126 MHz, CDCl3) of compound 9d. 
 
Infrared spectrum (Thin Film, NaCl) of compound 9d. 
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 13C NMR (126 MHz, CDCl3) of compound 9e. 
 
Infrared spectrum (Thin Film, NaCl) of compound 9e. 
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 13C NMR (126 MHz, CDCl3) of compound 9f. 
 
Infrared spectrum (Thin Film, NaCl) of compound 9f. 
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 13C NMR (126 MHz, CDCl3) of compound 9g. 
 
Infrared spectrum (Thin Film, NaCl) of compound 9g. 
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 13C NMR (126 MHz, CDCl3) of compound 9h. 
 
Infrared spectrum (Thin Film, NaCl) of compound 9h. 
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 13C NMR (126 MHz, CDCl3) of compound 9j. 
 
Infrared spectrum (Thin Film, NaCl) of compound 9j. 
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 13C NMR (126 MHz, CDCl3) of compound 9q. 
 
Infrared spectrum (Thin Film, NaCl) of compound 9q. 
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 13C NMR (126 MHz, CDCl3) of compound 16. 
 
Infrared spectrum (Thin Film, NaCl) of compound 16. 
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 13C NMR (126 MHz, CDCl3) of compound 10. 
 
Infrared spectrum (Thin Film, NaCl) of compound 10. 
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 13C NMR (126 MHz, CDCl3) of compound 11. 
 
Infrared spectrum (Thin Film, NaCl) of compound 11. 
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 13C NMR (126 MHz, CDCl3) of compound 12. 
 
Infrared spectrum (Thin Film, NaCl) of compound 12. 
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 13C NMR (126 MHz, CDCl3) of compound S11. 
 
Infrared spectrum (Thin Film, NaCl) of compound S11. 
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 13C NMR (126 MHz, CDCl3) of compound S12. 
 
Infrared spectrum (Thin Film, NaCl) of compound S12. 
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 13C NMR (126 MHz, CDCl3) of compound S13. 
 
Infrared spectrum (Thin Film, NaCl) of compound S13. 
 
Xing, O'Connor, and Stoltz Supporting Information
S161
  
 1 H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3)
 o
f c
om
po
un
d 
13
. 
 
 
Bn
N
O
Et
13
O
OM
e
Xing, O'Connor, and Stoltz Supporting Information
S162
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 13C NMR (126 MHz, CDCl3) of compound 13. 
 
Infrared spectrum (Thin Film, NaCl) of compound 13. 
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 13C NMR (126 MHz, CDCl3) of compound 14. 
 
Infrared spectrum (Thin Film, NaCl) of compound 14. 
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 13C NMR (126 MHz, CDCl3) of compound 15. 
 
Infrared spectrum (Thin Film, NaCl) of compound 15. 
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 13C NMR (126 MHz, CDCl3) of compound S14. 
 
Infrared spectrum (Thin Film, NaCl) of compound S14. 
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Crystallography Data for 3-(1-benzyl-3-ethyl-2-oxopiperidin-3-yl)-2,3-
dihydroxypropyl acetate (10) 
 
 
Low-temperature diffraction data (φ-and ω-scans) were collected on a Bruker 
AXS D8 VENTURE KAPPA diffractometer coupled to a PHOTON 100 CMOS detector 
with Cu Kα radiation (λ = 1.54178 Å) from an IµS micro-source for the structure of 
compound 10. The structure was solved by direct methods using SHELXS and refined 
against F2 on all data by full-matrix least squares with SHELXL-2014 using established 
refinement techniques. All non-hydrogen atoms were refined anisotropically. Unless 
otherwise noted, all hydrogen atoms were included into the model at geometrically 
calculated positions and refined using a riding model. The isotropic displacement 
parameters of all hydrogen atoms were fixed to 1.2 times the U value of the atoms they 
are linked to (1.5 times for methyl groups).  
Compound 10 crystallizes in the orthorhombic space group P212121 with one 
molecule in the asymmetric unit. The coordinates for the hydrogen atoms bound to O2 
and O3 were located in the difference Fourier synthesis and refined semi-freely with the 
help of a restraint on the O-H distance (0.84(4) Å).  
 
Table 1.  Crystal data and structure refinement for compound 10. 
CCDC deposition number 1057691 
Empirical formula  C19 H27 N O5 
Formula weight  349.41 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 7.8598(4) Å a= 90°. 
 b = 11.0342(6) Å b= 90°. 
 c = 20.5656(13) Å g = 90°. 
Volume 1783.58(17) Å3 
Z 4 
Density (calculated) 1.301 Mg/m3 
Absorption coefficient 0.767 mm-1 
F(000) 752 
N
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Crystal size 0.150 x 0.100 x 0.100 mm3 
Theta range for data collection 4.299 to 74.529°. 
Index ranges -9<=h<=9, -8<=k<=13, -25<=l<=25 
Reflections collected 12461 
Independent reflections 3592 [R(int) = 0.0553] 
Completeness to theta = 67.679° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7538 and 0.6907 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3592 / 2 / 234 
Goodness-of-fit on F2 1.056 
Final R indices [I>2sigma(I)] R1 = 0.0368, wR2 = 0.0729 
R indices (all data) R1 = 0.0470, wR2 = 0.0765 
Absolute structure parameter 0.00(14) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.182 and -0.201 e.Å-3 
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Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) 
for compound 10.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________ 
N(1) 3370(3) 3133(2) 986(1) 16(1) 
C(13) 1612(3) 3420(2) 809(1) 18(1) 
C(21) 831(3) 4438(2) 1206(1) 16(1) 
C(22) 282(3) 5492(2) 901(1) 18(1) 
C(23) -554(3) 6393(2) 1254(1) 21(1) 
C(24) -825(3) 6248(2) 1914(1) 23(1) 
C(25) -244(3) 5205(2) 2224(1) 22(1) 
C(26) 579(3) 4304(2) 1873(1) 19(1) 
C(1) 3702(3) 2140(2) 1342(1) 14(1) 
O(1) 2533(2) 1498(1) 1558(1) 17(1) 
C(2) 5551(3) 1718(2) 1435(1) 13(1) 
C(6) 5875(3) 1416(2) 2158(1) 14(1) 
O(2) 4694(2) 530(1) 2395(1) 16(1) 
C(7) 5905(3) 2505(2) 2618(1) 14(1) 
O(3) 4348(2) 3153(2) 2569(1) 17(1) 
C(8) 6201(3) 2075(2) 3309(1) 17(1) 
O(4) 6995(2) 3075(1) 3653(1) 17(1) 
O(5) 6468(3) 2166(2) 4609(1) 26(1) 
C(9) 7090(3) 2982(2) 4303(1) 18(1) 
C(10) 8103(4) 4004(2) 4588(1) 23(1) 
C(11) 5664(3) 524(2) 1031(1) 18(1) 
C(12) 7406(4) -94(2) 1031(2) 25(1) 
C(3) 6887(3) 2629(2) 1183(1) 16(1) 
C(4) 6245(3) 3928(2) 1163(1) 19(1) 
C(5) 4663(3) 3988(2) 751(1) 18(1) 
________________________________________________________________________
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Table 3.   Bond lengths [Å] and angles [°] for  compound 10. 
_____________________________________________________  
N(1)-C(1)  1.343(3) 
N(1)-C(13)  1.464(3) 
N(1)-C(5)  1.469(3) 
C(13)-C(21)  1.519(3) 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
C(21)-C(22)  1.390(3) 
C(21)-C(26)  1.394(4) 
C(22)-C(23)  1.395(4) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.384(4) 
C(23)-H(23)  0.9500 
C(24)-C(25)  1.392(4) 
C(24)-H(24)  0.9500 
C(25)-C(26)  1.388(4) 
C(25)-H(25)  0.9500 
C(26)-H(26)  0.9500 
C(1)-O(1)  1.241(3) 
C(1)-C(2)  1.539(3) 
C(2)-C(3)  1.543(3) 
C(2)-C(6)  1.544(3) 
C(2)-C(11)  1.560(3) 
C(6)-O(2)  1.434(3) 
C(6)-C(7)  1.530(3) 
C(6)-H(6)  1.0000 
O(2)-H(2O)  0.83(2) 
C(7)-O(3)  1.421(3) 
C(7)-C(8)  1.517(3) 
C(7)-H(7)  1.0000 
O(3)-H(3O)  0.83(2) 
C(8)-O(4)  1.452(3) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
O(4)-C(9)  1.344(3) 
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O(5)-C(9)  1.203(3) 
C(9)-C(10)  1.499(4) 
C(10)-H(10A)  0.9800 
C(10)-H(10B)  0.9800 
C(10)-H(10C)  0.9800 
C(11)-C(12)  1.529(4) 
C(11)-H(11A)  0.9900 
C(11)-H(11B)  0.9900 
C(12)-H(12A)  0.9800 
C(12)-H(12B)  0.9800 
C(12)-H(12C)  0.9800 
C(3)-C(4)  1.521(3) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(5)  1.505(4) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
 
C(1)-N(1)-C(13) 119.7(2) 
C(1)-N(1)-C(5) 124.7(2) 
C(13)-N(1)-C(5) 115.59(19) 
N(1)-C(13)-C(21) 114.0(2) 
N(1)-C(13)-H(13A) 108.8 
C(21)-C(13)-H(13A) 108.8 
N(1)-C(13)-H(13B) 108.8 
C(21)-C(13)-H(13B) 108.8 
H(13A)-C(13)-H(13B) 107.6 
C(22)-C(21)-C(26) 119.3(2) 
C(22)-C(21)-C(13) 120.0(2) 
C(26)-C(21)-C(13) 120.6(2) 
C(21)-C(22)-C(23) 120.6(3) 
C(21)-C(22)-H(22) 119.7 
C(23)-C(22)-H(22) 119.7 
C(24)-C(23)-C(22) 120.0(2) 
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C(24)-C(23)-H(23) 120.0 
C(22)-C(23)-H(23) 120.0 
C(23)-C(24)-C(25) 119.6(2) 
C(23)-C(24)-H(24) 120.2 
C(25)-C(24)-H(24) 120.2 
C(26)-C(25)-C(24) 120.5(3) 
C(26)-C(25)-H(25) 119.7 
C(24)-C(25)-H(25) 119.7 
C(25)-C(26)-C(21) 120.1(2) 
C(25)-C(26)-H(26) 120.0 
C(21)-C(26)-H(26) 120.0 
O(1)-C(1)-N(1) 121.1(2) 
O(1)-C(1)-C(2) 118.8(2) 
N(1)-C(1)-C(2) 119.9(2) 
C(1)-C(2)-C(3) 113.80(19) 
C(1)-C(2)-C(6) 109.93(19) 
C(3)-C(2)-C(6) 110.59(19) 
C(1)-C(2)-C(11) 104.10(18) 
C(3)-C(2)-C(11) 109.40(19) 
C(6)-C(2)-C(11) 108.73(19) 
O(2)-C(6)-C(7) 109.6(2) 
O(2)-C(6)-C(2) 111.61(19) 
C(7)-C(6)-C(2) 115.36(18) 
O(2)-C(6)-H(6) 106.6 
C(7)-C(6)-H(6) 106.6 
C(2)-C(6)-H(6) 106.6 
C(6)-O(2)-H(2O) 104(2) 
O(3)-C(7)-C(8) 110.8(2) 
O(3)-C(7)-C(6) 109.76(19) 
C(8)-C(7)-C(6) 109.65(18) 
O(3)-C(7)-H(7) 108.9 
C(8)-C(7)-H(7) 108.9 
C(6)-C(7)-H(7) 108.9 
C(7)-O(3)-H(3O) 109(2) 
O(4)-C(8)-C(7) 106.53(18) 
O(4)-C(8)-H(8A) 110.4 
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C(7)-C(8)-H(8A) 110.4 
O(4)-C(8)-H(8B) 110.4 
C(7)-C(8)-H(8B) 110.4 
H(8A)-C(8)-H(8B) 108.6 
C(9)-O(4)-C(8) 116.82(19) 
O(5)-C(9)-O(4) 123.7(2) 
O(5)-C(9)-C(10) 125.1(2) 
O(4)-C(9)-C(10) 111.1(2) 
C(9)-C(10)-H(10A) 109.5 
C(9)-C(10)-H(10B) 109.5 
H(10A)-C(10)-H(10B) 109.5 
C(9)-C(10)-H(10C) 109.5 
H(10A)-C(10)-H(10C) 109.5 
H(10B)-C(10)-H(10C) 109.5 
C(12)-C(11)-C(2) 115.3(2) 
C(12)-C(11)-H(11A) 108.4 
C(2)-C(11)-H(11A) 108.4 
C(12)-C(11)-H(11B) 108.4 
C(2)-C(11)-H(11B) 108.4 
H(11A)-C(11)-H(11B) 107.5 
C(11)-C(12)-H(12A) 109.5 
C(11)-C(12)-H(12B) 109.5 
H(12A)-C(12)-H(12B) 109.5 
C(11)-C(12)-H(12C) 109.5 
H(12A)-C(12)-H(12C) 109.5 
H(12B)-C(12)-H(12C) 109.5 
C(4)-C(3)-C(2) 113.4(2) 
C(4)-C(3)-H(3A) 108.9 
C(2)-C(3)-H(3A) 108.9 
C(4)-C(3)-H(3B) 108.9 
C(2)-C(3)-H(3B) 108.9 
H(3A)-C(3)-H(3B) 107.7 
C(5)-C(4)-C(3) 109.3(2) 
C(5)-C(4)-H(4A) 109.8 
C(3)-C(4)-H(4A) 109.8 
C(5)-C(4)-H(4B) 109.8 
Xing, O'Connor, and Stoltz Supporting Information
S176
C(3)-C(4)-H(4B) 109.8 
H(4A)-C(4)-H(4B) 108.3 
N(1)-C(5)-C(4) 111.0(2) 
N(1)-C(5)-H(5A) 109.4 
C(4)-C(5)-H(5A) 109.4 
N(1)-C(5)-H(5B) 109.4 
C(4)-C(5)-H(5B) 109.4 
H(5A)-C(5)-H(5B) 108.0 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Table 4.   Anisotropic displacement parameters  (Å2x 103) for compound 10.  The 
anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k 
a* b* U12 ] 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
N(1) 16(1)  15(1) 16(1)  2(1) -1(1)  0(1) 
C(13) 19(1)  20(1) 16(1)  -1(1) -5(1)  3(1) 
C(21) 12(1)  16(1) 21(1)  -2(1) -2(1)  -2(1) 
C(22) 15(1)  21(1) 19(1)  0(1) -1(1)  -4(1) 
C(23) 18(1)  14(1) 31(2)  1(1) -2(1)  -1(1) 
C(24) 18(1)  21(1) 31(2)  -9(1) 3(1)  -2(1) 
C(25) 18(1)  31(1) 18(2)  -4(1) 1(1)  -5(1) 
C(26) 17(1)  21(1) 20(1)  2(1) -1(1)  -2(1) 
C(1) 17(1)  13(1) 11(1)  -4(1) -1(1)  -1(1) 
O(1) 14(1)  17(1) 21(1)  0(1) 2(1)  -3(1) 
C(2) 11(1)  14(1) 14(1)  -1(1) 1(1)  -1(1) 
C(6) 12(1)  11(1) 17(1)  0(1) 1(1)  0(1) 
O(2) 20(1)  11(1) 19(1)  2(1) 1(1)  -2(1) 
C(7) 14(1)  12(1) 16(1)  0(1) -1(1)  1(1) 
O(3) 18(1)  10(1) 22(1)  -1(1) -1(1)  3(1) 
C(8) 22(1)  11(1) 17(1)  -2(1) -2(1)  0(1) 
O(4) 22(1)  15(1) 14(1)  -1(1) -4(1)  -1(1) 
O(5) 30(1)  31(1) 18(1)  3(1) 2(1)  -5(1) 
C(9) 17(1)  21(1) 15(1)  -1(1) -2(1)  4(1) 
C(10) 22(1)  25(1) 21(1)  -6(1) -2(1)  2(1) 
C(11) 20(1)  16(1) 18(1)  -1(1) 2(1)  0(1) 
C(12) 29(2)  20(1) 27(2)  -4(1) 5(1)  6(1) 
C(3) 14(1)  18(1) 17(1)  1(1) 2(1)  -2(1) 
C(4) 20(1)  16(1) 20(1)  1(1) 1(1)  -4(1) 
C(5) 22(1)  16(1) 18(1)  3(1) 3(1)  -1(1) 
________________________________________________________________________
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Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 
3) for compound 10. 
________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________  
  
H(13A) 908 2683 862 22 
H(13B) 1579 3649 343 22 
H(22) 477 5599 449 22 
H(23) -936 7107 1040 25 
H(24) -1403 6857 2155 28 
H(25) -414 5109 2678 27 
H(26) 972 3595 2089 23 
H(6) 7029 1037 2181 16 
H(2O) 3780(30) 710(30) 2213(14) 25 
H(7) 6860 3054 2489 17 
H(3O) 4550(40) 3884(19) 2621(15) 25 
H(8A) 5108 1855 3517 20 
H(8B) 6954 1356 3312 20 
H(10A) 7558 4284 4989 34 
H(10B) 8156 4674 4275 34 
H(10C) 9258 3723 4685 34 
H(11A) 4815 -56 1203 22 
H(11B) 5347 708 576 22 
H(12A) 8281 495 905 38 
H(12B) 7400 -766 719 38 
H(12C) 7654 -405 1467 38 
H(3A) 7903 2591 1467 20 
H(3B) 7241 2385 740 20 
H(4A) 5988 4211 1609 22 
H(4B) 7132 4463 977 22 
H(5A) 4197 4821 763 22 
H(5B) 4954 3793 295 22 
________________________________________________________________________
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Table 6.  Torsion angles [°] for compound 10. 
________________________________________________________________  
C(1)-N(1)-C(13)-C(21) 103.5(3) 
C(5)-N(1)-C(13)-C(21) -76.4(3) 
N(1)-C(13)-C(21)-C(22) 119.0(2) 
N(1)-C(13)-C(21)-C(26) -64.2(3) 
C(26)-C(21)-C(22)-C(23) -1.7(4) 
C(13)-C(21)-C(22)-C(23) 175.1(2) 
C(21)-C(22)-C(23)-C(24) 0.7(4) 
C(22)-C(23)-C(24)-C(25) 0.6(4) 
C(23)-C(24)-C(25)-C(26) -1.0(4) 
C(24)-C(25)-C(26)-C(21) -0.1(4) 
C(22)-C(21)-C(26)-C(25) 1.4(4) 
C(13)-C(21)-C(26)-C(25) -175.4(2) 
C(13)-N(1)-C(1)-O(1) -4.4(3) 
C(5)-N(1)-C(1)-O(1) 175.6(2) 
C(13)-N(1)-C(1)-C(2) 169.9(2) 
C(5)-N(1)-C(1)-C(2) -10.1(3) 
O(1)-C(1)-C(2)-C(3) -176.6(2) 
N(1)-C(1)-C(2)-C(3) 9.0(3) 
O(1)-C(1)-C(2)-C(6) -51.9(3) 
N(1)-C(1)-C(2)-C(6) 133.7(2) 
O(1)-C(1)-C(2)-C(11) 64.4(3) 
N(1)-C(1)-C(2)-C(11) -110.0(2) 
C(1)-C(2)-C(6)-O(2) 56.0(2) 
C(3)-C(2)-C(6)-O(2) -177.47(19) 
C(11)-C(2)-C(6)-O(2) -57.3(2) 
C(1)-C(2)-C(6)-C(7) -69.9(2) 
C(3)-C(2)-C(6)-C(7) 56.6(3) 
C(11)-C(2)-C(6)-C(7) 176.78(19) 
O(2)-C(6)-C(7)-O(3) -70.0(2) 
C(2)-C(6)-C(7)-O(3) 57.0(3) 
O(2)-C(6)-C(7)-C(8) 52.0(3) 
C(2)-C(6)-C(7)-C(8) 178.9(2) 
O(3)-C(7)-C(8)-O(4) -84.9(2) 
C(6)-C(7)-C(8)-O(4) 153.74(19) 
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C(7)-C(8)-O(4)-C(9) 168.1(2) 
C(8)-O(4)-C(9)-O(5) -4.8(4) 
C(8)-O(4)-C(9)-C(10) 173.7(2) 
C(1)-C(2)-C(11)-C(12) 179.2(2) 
C(3)-C(2)-C(11)-C(12) 57.3(3) 
C(6)-C(2)-C(11)-C(12) -63.6(3) 
C(1)-C(2)-C(3)-C(4) 24.6(3) 
C(6)-C(2)-C(3)-C(4) -99.7(2) 
C(11)-C(2)-C(3)-C(4) 140.5(2) 
C(2)-C(3)-C(4)-C(5) -56.6(3) 
C(1)-N(1)-C(5)-C(4) -23.0(3) 
C(13)-N(1)-C(5)-C(4) 156.9(2) 
C(3)-C(4)-C(5)-N(1) 55.1(3) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Table 7.  Hydrogen bonds for compound 10  [Å and °]. 
________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________  
 O(2)-H(2O)...O(1) 0.83(2) 1.88(2) 2.645(2) 152(3) 
 O(3)-H(3O)...O(2)#1 0.83(2) 1.91(2) 2.730(2) 169(3) 
 C(10)-H(10C)...O(5)#2 0.98 2.47 3.374(3) 153.9 
 C(4)-H(4A)...O(2)#1 0.99 2.57 3.530(3) 163.7 
 C(4)-H(4A)...O(3) 0.99 2.63 3.364(3) 131.0 
________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,y+1/2,-z+1/2    #2 x+1/2,-y+1/2,-z+1       
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